
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Organon & Co Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 9.2% Above Pre-Pandemic Base- Week 90</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">01/08/2022</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Organon & Co: Updated Model: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">OGN</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / COMPANY / COMPANY REPORT / COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/08/2022</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">OGN: Updated Model: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">OGN</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / COMPANY / COMPANY REPORT / COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VTRS-US -  Dividend Quality Analysis, for the period ended December 16,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">VTRS.O / OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">Viatris Inc / Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ODT-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MBRX-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MBRX.O / OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">Moleculin Biotech Inc / Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ELDN-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ELDN.O / OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">Eledon Pharmaceuticals Inc / Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RZLT-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">RZLT.O / OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">Rezolute Inc / Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SIOX-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SIOX.O / OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">Sio Gene Therapies Inc / Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EQ-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">EQ.O / OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">Equillium Inc / Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SCPH-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SCPH.O / OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">scPharmaceuticals Inc / Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALLK-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ALLK.O / OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">Allakos Inc / Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MDGL-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MDGL.O / OGN / OILS.CD / OMHE.PK / ONPH.PK</td><td class="leftalignment">Madrigal Pharmaceuticals Inc / Organon & Co / Nextleaf Solutions Ltd / Omni Health Inc / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for OGN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">68622V106</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Yield Coverage Report : Healthcare</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AVTR.N / BHC.N / CHNG.O / CNC.N / CTLT.N / CYH.N / DVA.N / EHC.N / ENDP.O / HCA.N / HOLX.O / IQV.N / MD.N / MNKKQ.PK / MPLN.N / OGN.N / SEM / SYNH.O / TEVA.N / TFX / THC.N / UHS.N</td><td class="leftalignment">Avantor Inc / Bausch Health Companies Inc / Change Healthcare Inc / Centene Corp / Catalent Inc / Community Health Systems Inc / DaVita Inc / Encompass Health Corp / Endo International PLC / HCA Healthcare Inc / Hologic Inc / IQVIA Holdings Inc / MEDNAX Inc / Mallinckrodt PLC / Multiplan Corp / Organon & Co / Select Medical Holdings Corp / Syneos Health Inc / Teva Pharmaceutical Industries Ltd / Teleflex Inc / Tenet Healthcare Corp / Universal Health Services Inc</td><td class="leftalignment">FIXED INCOME - HIGH YIELD</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS</td><td class="leftalignment">David Common / Mr. Bradley H. Cobb</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">TheScreener</td><td class="leftalignment">ORGANON sees an upgrade to Slightly Positive due to a better fundamental star rating</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">82982L103 / AMGN=US / AMRX=US / APLT=US / AWI=US / AZEK=US / BECN=US / BLD=US / BLDR=US / BLL=US / CADE=US / CATY=US / CCK=US / CFR=US / CMA=US / CMG=US / CNM=US / DASH=US / EWBC=US / EXP=US / FBHS=US / FERG=US / FHN=US / FMBI=US / FNB=US / GFF=US / GMS=US / GPOR=US / HD=US / HWC=US / IBP=US / JELD=US / LEG=US / LLY=US / LOB=US / LOW=US / MAS=US / MBIN=US / MHK=US / MLM=US / MTN=US / NDLS=US / OC=US / OGN / OZK=US / PACW=US / PB=US / PFE=US / PGTI=US / PNFP=US / PRPL=US / RF=US / SHAK=US / SIVB=US / SNPO=US / SNV=US / SPOT=US / SSB=US / SWIM=US / TCBI=US / TILE=US / TPX=US / TREX=US / TXRH=US / UMPQ=US / VMC=US / VTRS=US / WAL=US / WING=US / XPO=US / ZION=US</td><td class="leftalignment">SiteOne Landscape Supply Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Applied Therapeutics Inc / Armstrong World Industries Inc / Azek Company Inc / Beacon Roofing Supply Inc / TopBuild Corp / Builders FirstSource Inc / Ball Corp / Cadence Bank / Cathay General Bancorp / Crown Holdings Inc / Cullen/Frost Bankers Inc / Comerica Inc / Chipotle Mexican Grill Inc / Core & Main Inc / DoorDash Inc / East West Bancorp Inc / Eagle Materials Inc / Fortune Brands Home & Security Inc / Ferguson PLC / First Horizon Corp / First Midwest Bancorp Inc / FNB Corp / Griffon Corp / GMS Inc / Gulfport Energy Corp / Home Depot Inc / Hancock Whitney Corp / Installed Building Products Inc / JELD-WEN Holding Inc / Leggett & Platt Inc / Eli Lilly and Co / Live Oak Bancshares Inc / Lowe's Companies Inc / Masco Corp / Merchants Bancorp / Mohawk Industries Inc / Martin Marietta Materials Inc / Vail Resorts Inc / Noodles & Co / Owens Corning / Organon & Co / Bank Ozk / PacWest Bancorp / Prosperity Bancshares Inc / Pfizer Inc / PGT Innovations Inc / Pinnacle Financial Partners Inc / Purple Innovation Inc / Regions Financial Corp / Shake Shack Inc / SVB Financial Group / Snap One Holdings Corp / Synovus Financial Corp / Spotify Technology SA / SouthState Corp / Latham Group Inc / Texas Capital Bancshares Inc / Interface Inc / Tempur Sealy International Inc / Trex Company Inc / Texas Roadhouse Inc / Umpqua Holdings Corp / Vulcan Materials Co / Viatris Inc / Western Alliance Bancorp / Wingstop Inc / XPO Logistics Inc / Zions Bancorporation NA</td><td class="leftalignment"></td><td class="leftalignment">Jersey / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Organon & Co climbs 8.5% in past month</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">AMGN=US / AMRX=US / LLY=US / OGN / PFE=US / VTRS=US</td><td class="leftalignment">Amgen Inc / Amneal Pharmaceuticals Inc / Eli Lilly and Co / Organon & Co / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">CA68707R1038</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">Canada</td><td class="leftalignment">Miscellaneous</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / STRATEGIC ANALYSIS / TUESDAY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">82982L103 / AMGN=US / AMRX=US / APPN=US / AWI=US / AXNX=US / AZEK=US / AZYO=US / BDSI=US / BECN=US / BIIB=US / BLD=US / BLDR=US / BSX=US / CBRL=US / CCL=US / CHH=US / CMG=US / CNM=US / CRM=US / CRSP=US / DASH=US / DENN=US / DIN=US / DKS=US / DNUT=US / DRH=US / DRI=US / EVBG=US / EXP=US / FBHS=US / FERG=US / GFF=US / GMED=US / GMS=US / H=US / HD=US / HGV=US / HLT=US / HST=US / IART=US / IBP=US / IRTC=US / JACK=US / JELD=US / KIDS=US / LEG=US / LLY=US / LOCO=US / LOW=US / LYFT=US / MANH=US / MAR=US / MAS=US / MCD=US / MDT=US / MHK=US / MLM=US / MTN=US / NDLS=US / NKE=US / NUVA=US / NVRO=US / OC=US / OGN / OLO=US / PATH=US / PEB=US / PEN=US / PFE=US / PGTI=US / PK=US / PLAY=US / PLYA=US / PRPL=US / PYPL=US / QSR=US / RHP=US / RLJ=US / ROIV=US / SHAK=US / SHO=US / SIBN=US / SMAR=US / SNPO=US / SPNE=US / SWIM=US / TAST=US / TILE=US / TNL=US / TPX=US / TREX=US / TXRH=US / UBER=US / VAC=US / VCEL=US / VMC=US / VRTX=US / VTRS=US / WEN=US / WH=US / WING=US / ZBH=US</td><td class="leftalignment">SiteOne Landscape Supply Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Appian Corp / Armstrong World Industries Inc / Axonics Inc / Azek Company Inc / Aziyo Biologics Inc / BioDelivery Sciences International Inc / Beacon Roofing Supply Inc / Biogen Inc / TopBuild Corp / Builders FirstSource Inc / Boston Scientific Corp / Cracker Barrel Old Country Store Inc / Carnival Corp / Choice Hotels International Inc / Chipotle Mexican Grill Inc / Core & Main Inc / Salesforce.Com Inc / CRISPR Therapeutics AG / DoorDash Inc / Denny's Corp / Dine Brands Global Inc / DICK'S Sporting Goods Inc / Krispy Kreme Inc / Diamondrock Hospitality Co / Darden Restaurants Inc / Everbridge Inc / Eagle Materials Inc / Fortune Brands Home & Security Inc / Ferguson PLC / Griffon Corp / Globus Medical Inc / GMS Inc / Hyatt Hotels Corp / Home Depot Inc / Hilton Grand Vacations Inc / Hilton Worldwide Holdings Inc / Host Hotels & Resorts Inc / Integra Lifesciences Holdings Corp / Installed Building Products Inc / iRhythm Technologies Inc / Jack in the Box Inc / JELD-WEN Holding Inc / OrthoPediatrics Corp / Leggett & Platt Inc / Eli Lilly and Co / El Pollo Loco Holdings Inc / Lowe's Companies Inc / Lyft Inc / Manhattan Associates Inc / Marriott International Inc / Masco Corp / McDonald's Corp / Medtronic PLC / Mohawk Industries Inc / Martin Marietta Materials Inc / Vail Resorts Inc / Noodles & Co / Nike Inc / NuVasive Inc / Nevro Corp / Owens Corning / Organon & Co / Olo Inc / UiPath Inc / Pebblebrook Hotel Trust / Penumbra Inc / Pfizer Inc / PGT Innovations Inc / Park Hotels & Resorts Inc / Dave & Buster's Entertainment Inc / Playa Hotels & Resorts NV / Purple Innovation Inc / PayPal Holdings Inc / Restaurant Brands International Inc / Ryman Hospitality Properties Inc / RLJ Lodging Trust / Roivant Sciences Ltd / Shake Shack Inc / Sunstone Hotel Investors Inc / SI-BONE Inc / Smartsheet Inc / Snap One Holdings Corp / SeaSpine Holdings Corp / Latham Group Inc / Carrols Restaurant Group Inc / Interface Inc / Travel + Leisure Co / Tempur Sealy International Inc / Trex Company Inc / Texas Roadhouse Inc / Uber Technologies Inc / Marriott Vacations Worldwide Corp / Vericel Corp / Vulcan Materials Co / Vertex Pharmaceuticals Inc / Viatris Inc / Wendys Co / Wyndham Hotels & Resorts Inc / Wingstop Inc / Zimmer Biomet Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Jersey / Netherlands / Panama / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN=US / AMRX=US / LLY=US / OGN / PFE=US / VTRS=US</td><td class="leftalignment">Amgen Inc / Amneal Pharmaceuticals Inc / Eli Lilly and Co / Organon & Co / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">12/18/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Orogen Royalties Inc</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">OGN.V</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Forendo Deal Adds Early, But Promising Asset; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">82982L103 / ADI=US / AMD=US / AMGN=US / AMRX=US / ANGI=US / APH=US / ARW=US / AUTL=US / AVGO=US / AVT=US / AWI=US / AZEK=US / BDC=US / BECN=US / BERY=US / BKI=US / BLD=US / BLDR=US / CBRL=US / CHKP=US / CMG=US / CNM=US / CRWD=US / CVS=US / DENN=US / DIN=US / DIOD=US / DIS=US / DOC=US / DRI=US / EQT=US / EXP=US / FAF=US / FATE=US / FB=US / FBHS=US / FERG=US / FORG=US / GBT=US / GFF=US / GMS=US / GTLB=US / HD=US / IAC=US / IBP=US / INTC=US / JACK=US / JELD=US / KNBE=US / LEG=US / LLY=US / LOCO=US / LOW=US / LPLA=US / MAS=US / MCD=US / MCHP=US / MHK=US / MIME=US / MLM=US / MNDT=US / MPWR=US / NDLS=US / NET=US / NVDA=US / NXPI=US / OC=US / OGN / OKTA=US / ON=US / PANW=US / PFE=US / PG=US / PGTI=US / PLAY=US / PRPL=US / QLYS=US / QSR=US / RBLX=US / REPX=US / RPD=US / SAIL=US / SEIC=US / SHAK=US / SNPO=US / STRA=US / SWIM=US / TAST=US / TDG=US / TEL=US / TENB=US / TILE=US / TPX=US / TREX=US / TTMI=US / TXN=US / TXRH=US / VMC=US / VMEO=US / VRNS=US / VTRS=US / WEN=US / WING=US / XLNX=US / ZS=US</td><td class="leftalignment">SiteOne Landscape Supply Inc / Analog Devices Inc / Advanced Micro Devices Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Angi Inc / Amphenol Corp / Arrow Electronics Inc / Autolus Therapeutics PLC / Broadcom Inc / Avnet Inc / Armstrong World Industries Inc / Azek Company Inc / Belden Inc / Beacon Roofing Supply Inc / Berry Global Group Inc / Black Knight Inc / TopBuild Corp / Builders FirstSource Inc / Cracker Barrel Old Country Store Inc / Check Point Software Technologies Ltd / Chipotle Mexican Grill Inc / Core & Main Inc / CrowdStrike Holdings Inc / CVS Health Corp / Denny's Corp / Dine Brands Global Inc / Diodes Inc / Walt Disney Co / Physicians Realty Trust / Darden Restaurants Inc / EQT Corp / Eagle Materials Inc / First American Financial Corp / Fate Therapeutics Inc / Meta Platforms Inc / Fortune Brands Home & Security Inc / Ferguson PLC / ForgeRock Inc / Global Blood Therapeutics Inc / Griffon Corp / GMS Inc / GitLab Inc / Home Depot Inc / IAC/Interactivecorp / Installed Building Products Inc / Intel Corp / Jack in the Box Inc / JELD-WEN Holding Inc / Knowbe4 Inc / Leggett & Platt Inc / Eli Lilly and Co / El Pollo Loco Holdings Inc / Lowe's Companies Inc / LPL Financial Holdings Inc / Masco Corp / McDonald's Corp / Microchip Technology Inc / Mohawk Industries Inc / Mimecast Ltd / Martin Marietta Materials Inc / Mandiant Inc / Monolithic Power Systems Inc / Noodles & Co / Cloudflare Inc / NVIDIA Corp / NXP Semiconductors NV / Owens Corning / Organon & Co / Okta Inc / ON Semiconductor Corp / Palo Alto Networks Inc / Pfizer Inc / Procter & Gamble Co / PGT Innovations Inc / Dave & Buster's Entertainment Inc / Purple Innovation Inc / Qualys Inc / Restaurant Brands International Inc / Roblox Corp / Riley Exploration Permian Inc / Rapid7 Inc / SailPoint Technologies Holdings Inc / SEI Investments Co / Shake Shack Inc / Snap One Holdings Corp / Strategic Education Inc / Latham Group Inc / Carrols Restaurant Group Inc / TransDigm Group Inc / TE Connectivity Ltd / Tenable Holdings Inc / Interface Inc / Tempur Sealy International Inc / Trex Company Inc / TTM Technologies Inc / Texas Instruments Inc / Texas Roadhouse Inc / Vulcan Materials Co / Vimeo Inc / Varonis Systems Inc / Viatris Inc / Wendys Co / Wingstop Inc / Xilinx Inc / Zscaler Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Jersey / Netherlands / Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Organon & Co</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Osisko Sees Record Revenues With Projects Advancing</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">OR.TO / ABX.TO / AEM.TO / ECR.V / FVI.TO / HPHT-D.SI / LRA.V / MD.V / NEM.N / OGN.V / PAAS.TO / RGLD.OQ / VGZ.A</td><td class="leftalignment">Osisko Gold Royalties Ltd / Barrick Gold Corp / Agnico Eagle Mines Ltd / Cartier Resources Inc / Fortuna Silver Mines Inc / Hutchison Port Holdings Trust / Lara Exploration Ltd / Midland Exploration Inc / Newmont Corporation / Orogen Royalties Inc / Pan American Silver Corp / Royal Gold Inc / Vista Gold Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Singapore / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products / Shipping & Shipbuilding</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / SECTOR</td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN=US / AMRX=US / LLY=US / OGN / PFE=US / VTRS=US</td><td class="leftalignment">Amgen Inc / Amneal Pharmaceuticals Inc / Eli Lilly and Co / Organon & Co / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 88</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Organon & Co sinks 22% in past month</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">KOL/OGN Management Call Highlights Opportunities In Women's Health</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">50189K103 / 82982L103 / AFMD=US / AGS=US / ALLO=US / AMD=US / AMED=US / AMGN=US / AMRX=US / AUTL=US / AWI=US / AZEK=US / BALY=US / BCO=US / BECN=US / BLD=US / BLDR=US / BVH=US / BYD=US / CBRL=US / CCL=US / CELU=US / CHH=US / CMG=US / CNM=US / COP=US / COUP=US / CZR=US / DENN=US / DIN=US / DKNG=US / DRH=US / DRI=US / ELY=US / EVRI=US / EXP=US / FANG=US / FATE=US / FBHS=US / FERG=US / FOXF=US / FUN=US / GFF=US / GLPI=US / GMAB=US / GMS=US / GTLB=US / H=US / HARP=US / HD=US / HGV=US / HLLY=US / HLT=US / HST=US / IBP=US / IGT=US / INTC=US / IOVA=US / IP=US / JACK=US / JELD=US / KMI=US / LEG=US / LLY=US / LOCO=US / LOW=US / LPLA=US / MAR=US / MAS=US / MCD=US / MGM=US / MGP=US / MHK=US / MLM=US / MRNS=US / MTN=US / NCLH=US / NDLS=US / NLS=US / OC=US / OGN / ONEW=US / PEB=US / PENN=US / PFE=US / PGTI=US / PKG=U / PLAY=US / PRG=US / PRPL=US / QSR=US / RCL=US / REGN=US / REX=US / RHP=US / ROCC=US / RRR=US / SAIC=US / SGMS=US / SHAK=US / SHO=US / SIVB=US / SLG=US / SNPO=US / SWIM=US / TAST=US / TILE=US / TNL=US / TPX=US / TREX=US / TXRH=US / UNH=US / VAC=US / VICI=US / VMC=US / VTRS=US / WEN=US / WGO=US / WH=US / WING=US / WRK=US</td><td class="leftalignment">LCI Industries / SiteOne Landscape Supply Inc / Affimed NV / PlayAGS Inc / Allogene Therapeutics Inc / Advanced Micro Devices Inc / Amedisys Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Autolus Therapeutics PLC / Armstrong World Industries Inc / Azek Company Inc / Bally's Corp / Brinks Co / Beacon Roofing Supply Inc / TopBuild Corp / Builders FirstSource Inc / Bluegreen Vacations Holding Corp / Boyd Gaming Corp / Cracker Barrel Old Country Store Inc / Carnival Corp / Celularity Inc / Choice Hotels International Inc / Chipotle Mexican Grill Inc / Core & Main Inc / Conocophillips / Coupa Software Inc / Caesars Entertainment Inc / Denny's Corp / Dine Brands Global Inc / DraftKings Inc / Diamondrock Hospitality Co / Darden Restaurants Inc / Callaway Golf Co / Everi Holdings Inc / Eagle Materials Inc / Diamondback Energy Inc / Fate Therapeutics Inc / Fortune Brands Home & Security Inc / Ferguson PLC / Fox Factory Holding Corp / Cedar Fair LP / Griffon Corp / Gaming and Leisure Properties Inc / Genmab A/S / GMS Inc / GitLab Inc / Hyatt Hotels Corp / Harpoon Therapeutics Inc / Home Depot Inc / Hilton Grand Vacations Inc / Holley Inc / Hilton Worldwide Holdings Inc / Host Hotels & Resorts Inc / Installed Building Products Inc / International Game Technology PLC / Intel Corp / Iovance Biotherapeutics Inc / International Paper Co / Jack in the Box Inc / JELD-WEN Holding Inc / Kinder Morgan Inc / Leggett & Platt Inc / Eli Lilly and Co / El Pollo Loco Holdings Inc / Lowe's Companies Inc / LPL Financial Holdings Inc / Marriott International Inc / Masco Corp / McDonald's Corp / MGM Resorts International / MGM Growth Properties LLC / Mohawk Industries Inc / Martin Marietta Materials Inc / Marinus Pharmaceuticals Inc / Vail Resorts Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Nautilus Inc / Owens Corning / Organon & Co / OneWater Marine Inc / Pebblebrook Hotel Trust / Penn National Gaming Inc / Pfizer Inc / PGT Innovations Inc / Packaging Corp of America / Dave & Buster's Entertainment Inc / PROG Holdings Inc / Purple Innovation Inc / Restaurant Brands International Inc / Royal Caribbean Cruises Ltd / Regeneron Pharmaceuticals Inc / REX American Resources Corp / Ryman Hospitality Properties Inc / Ranger Oil Corp / Red Rock Resorts Inc / Science Applications International Corp / Scientific Games Corp / Shake Shack Inc / Sunstone Hotel Investors Inc / SVB Financial Group / SL Green Realty Corp / Snap One Holdings Corp / Latham Group Inc / Carrols Restaurant Group Inc / Interface Inc / Travel + Leisure Co / Tempur Sealy International Inc / Trex Company Inc / Texas Roadhouse Inc / UnitedHealth Group Inc / Marriott Vacations Worldwide Corp / VICI Properties Inc / Vulcan Materials Co / Viatris Inc / Wendys Co / Winnebago Industries Inc / Wyndham Hotels & Resorts Inc / Wingstop Inc / Westrock Co</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / Jersey / Liberia / Netherlands / Panama / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN=US / AMRX=US / LLY=US / OGN / PFE=US / VTRS=US</td><td class="leftalignment">Amgen Inc / Amneal Pharmaceuticals Inc / Eli Lilly and Co / Organon & Co / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">12/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 87</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Live @ The PSC Healthcare Conference: Discussions On Generics And Biosimilars</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03168L105 / 68622V106 / 881624209 / 92556V106 / G30401106</td><td class="leftalignment">Amneal Pharmaceuticals Inc / Organon & Co / Teva Pharmaceutical Industries Ltd / Viatris Inc / Endo International PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">OGN.N - Event Transcript of Organon & Co conference call, Dec. 01, 2021 / 1:50PM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Laurentian Bank Securities</td><td class="leftalignment">Model Inputs from Santa Elena PFS Pull Ermitano Valuation Lower; Lowering TP and Downgrading to Hold</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">OGN=CA</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Industrial Materials / Metals & Minerals</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jacques Wortman</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">00770K202 / 67421J108 / 82982L103 / ABNB=US / AFMD=US / AMGN=US / AMRX=US / AWI=US / AZEK=US / BECN=US / BERY=US / BKNG=US / BLD=US / BLDR=US / BLL=US / BRBR=US / CBRL=US / CHD=US / CMG=US / CNM=US / DENN=US / DIN=US / DNUT=US / DRI=US / EXP=US / EXPE=US / FATE=US / FB=US / FBHS=US / FERG=US / FRPT=US / GFF=US / GMS=US / GPRE=US / HD=US / IBP=US / IRTC=US / JACK=US / JELD=US / LEG=US / LLY=US / LOCO=US / LOW=US / MAS=US / MCD=US / MGNI=US / MHK=US / MLM=US / MNST=US / NDLS=US / OC=US / OGN / OI=US / PFE=US / PG=US / PGTI=US / PLAY=US / PNFP=US / PRPL=US / QSR=US / REGI=US / REX=US / RGF=US / SEE=US / SGMO=US / SHAK=US / SIVB=US / SNPO=US / SWIM=US / SWN=US / TAST=US / TILE=US / TPX=US / TREX=US / TRIP=US / TRVG=US / TWTR=US / TXRH=US / VMC=US / VTRS=US / WEN=US / WING=US / YEXT=US</td><td class="leftalignment">Aemetis Inc / Oatly Group AB / SiteOne Landscape Supply Inc / Airbnb Inc / Affimed NV / Amgen Inc / Amneal Pharmaceuticals Inc / Armstrong World Industries Inc / Azek Company Inc / Beacon Roofing Supply Inc / Berry Global Group Inc / Booking Holdings Inc / TopBuild Corp / Builders FirstSource Inc / Ball Corp / Bellring Brands Inc / Cracker Barrel Old Country Store Inc / Church & Dwight Co Inc / Chipotle Mexican Grill Inc / Core & Main Inc / Denny's Corp / Dine Brands Global Inc / Krispy Kreme Inc / Darden Restaurants Inc / Eagle Materials Inc / Expedia Group Inc / Fate Therapeutics Inc / Meta Platforms Inc / Fortune Brands Home & Security Inc / Ferguson PLC / Freshpet Inc / Griffon Corp / GMS Inc / Green Plains Inc / Home Depot Inc / Installed Building Products Inc / iRhythm Technologies Inc / Jack in the Box Inc / JELD-WEN Holding Inc / Leggett & Platt Inc / Eli Lilly and Co / El Pollo Loco Holdings Inc / Lowe's Companies Inc / Masco Corp / McDonald's Corp / Magnite Inc / Mohawk Industries Inc / Martin Marietta Materials Inc / Monster Beverage Corp / Noodles & Co / Owens Corning / Organon & Co / O-I Glass Inc / Pfizer Inc / Procter & Gamble Co / PGT Innovations Inc / Dave & Buster's Entertainment Inc / Pinnacle Financial Partners Inc / Purple Innovation Inc / Restaurant Brands International Inc / Renewable Energy Group Inc / REX American Resources Corp / Real Good Food Company Inc / Sealed Air Corp / Sangamo Therapeutics Inc / Shake Shack Inc / SVB Financial Group / Snap One Holdings Corp / Latham Group Inc / Southwestern Energy Co / Carrols Restaurant Group Inc / Interface Inc / Tempur Sealy International Inc / Trex Company Inc / Tripadvisor Inc / Trivago NV / Twitter Inc / Texas Roadhouse Inc / Vulcan Materials Co / Viatris Inc / Wendys Co / Wingstop Inc / Yext Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Jersey / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN=US / AMRX=US / LLY=US / OGN / PFE=US / VTRS=US</td><td class="leftalignment">Amgen Inc / Amneal Pharmaceuticals Inc / Eli Lilly and Co / Organon & Co / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 86</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Large Royalty Company Shifts Talk on Diversification as It Grows</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">FNV.TO / ABX.TO / AEM.TO / ALS.TO / ECR.V / FVI.TO / KMEN.SI / LRA.V / MD.V / NEM.N / OGN.V / PAAS.TO</td><td class="leftalignment">Franco-Nevada Corp / Barrick Gold Corp / Agnico Eagle Mines Ltd / Altius Minerals Corp / Cartier Resources Inc / Fortuna Silver Mines Inc / Kingsmen Creatives Ltd / Lara Exploration Ltd / Midland Exploration Inc / Newmont Corporation / Orogen Royalties Inc / Pan American Silver Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Singapore / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / SECTOR</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMRX-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMRX.K / OFSA3.SA / OGN / OILS.CD / ONPH.PK</td><td class="leftalignment">Amneal Pharmaceuticals Inc / Ouro Fino Saude Animal Participacoes SA / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">82982L103 / ABNB=US / AFMD=US / AFRM=US / AJRD=US / AMGN=US / AMRX=US / AMZN=US / APA=US / APPN=US / AR=US / AWI=US / AZEK=US / BECN=US / BKI=US / BKNG=US / BLD=US / BLDR=US / CBRL=US / CDEV=US / CENT=US / CENTA=US / CIVI=US / CLR=US / CMG=US / CNM=US / CNX=US / COP=US / COUP=US / COUR=US / CPE=US / CRK=US / CSGP=US / CTRA=US / CVX=US / DENN=US / DIN=US / DNB / DRI=US / DVN=US / EEFT=US / EFX=US / EOG=US / EQT=US / ESTE=US / EVOP=US / EXP=US / EXPE=US / FANG=US / FB=US / FBHS=US / FERG=US / FIS=US / FISV=US / FLT=US / FOUR=US / GDOT=US / GFF=US / GMS=US / GOOGL=US / GPN=US / GPOR=US / HD=US / HRT=US / IBEX=US / IBP=US / INST=US / JACK=US / JELD=US / KTOS=US / LEG=US / LHX=US / LLY=US / LOCO=US / LOW=US / LSPD=US / MA=US / MAS=US / MAXR=US / MCD=US / MGY=US / MHK=US / MLM=US / MQ / MRO=US / MTDR=US / MUR=US / NDLS=US / NOG=US / OAS=US / OC=US / OGN / OVV=US / OXY=US / PATH=US / PAYA=US / PCTY=US / PDCE=US / PFE=US / PGTI=US / PLAY=US / PRPL=US / PXD=US / PYPL=US / QSR=US / REI=US / REPX=US / ROCC=US / RPAY=US / RRC=US / SBOW=US / SHAK=US / SNPO=US / SPCE=US / SQ=US / SSNC=US / SWIM=US / SWN=US / TAST=US / TILE=US / TPX=US / TREX=US / TRIP=US / TRU=US / TRVG=US / TXRH=US / UBER=US / UDMY=US / UNH=US / V=US / VMC=US / VNO=US / VNOM=US / VRSK=US / VTRS=US / WEN=US / WEX=US / WING=US / WLL=US / WU=US / XM=US / XOM=US</td><td class="leftalignment">SiteOne Landscape Supply Inc / Airbnb Inc / Affimed NV / Affirm Holdings Inc / Aerojet Rocketdyne Holdings Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Amazon.com Inc / APA Corp (US) / Appian Corp / Antero Resources Corp / Armstrong World Industries Inc / Azek Company Inc / Beacon Roofing Supply Inc / Black Knight Inc / Booking Holdings Inc / TopBuild Corp / Builders FirstSource Inc / Cracker Barrel Old Country Store Inc / Centennial Resource Development Inc / Central Garden & Pet Co / Central Garden & Pet Co / Civitas Resources Inc / Continental Resources Inc / Chipotle Mexican Grill Inc / Core & Main Inc / CNX Resources Corp / Conocophillips / Coupa Software Inc / Coursera Inc / Callon Petroleum Co / Comstock Resources Inc / CoStar Group Inc / Coterra Energy Inc / Chevron Corp / Denny's Corp / Dine Brands Global Inc / Dun & Bradstreet Holdings Inc / Darden Restaurants Inc / Devon Energy Corp / Euronet Worldwide Inc / Equifax Inc / EOG Resources Inc / EQT Corp / Earthstone Energy Inc / EVO Payments Inc / Eagle Materials Inc / Expedia Group Inc / Diamondback Energy Inc / Meta Platforms Inc / Fortune Brands Home & Security Inc / Ferguson PLC / Fidelity National Information Services Inc / Fiserv Inc / Fleetcor Technologies Inc / Shift4 Payments Inc / Green Dot Corp / Griffon Corp / GMS Inc / Alphabet Inc / Global Payments Inc / Gulfport Energy Corp / Home Depot Inc / HireRight Holdings Corp / Ibex Ltd / Installed Building Products Inc / Instructure Holdings Inc / Jack in the Box Inc / JELD-WEN Holding Inc / Kratos Defense and Security Solutions Inc / Leggett & Platt Inc / L3harris Technologies Inc / Eli Lilly and Co / El Pollo Loco Holdings Inc / Lowe's Companies Inc / Lightspeed Commerce Inc / Mastercard Inc / Masco Corp / Maxar Technologies Inc / McDonald's Corp / Magnolia Oil & Gas Corp / Mohawk Industries Inc / Martin Marietta Materials Inc / Marqeta Inc / Marathon Oil Corp / Matador Resources Co / Murphy Oil Corp / Noodles & Co / Northern Oil and Gas Inc / Oasis Petroleum Inc / Owens Corning / Organon & Co / Ovintiv Inc / Occidental Petroleum Corp / UiPath Inc / Paya Holdings Inc / Paylocity Holding Corp / PDC Energy Inc / Pfizer Inc / PGT Innovations Inc / Dave & Buster's Entertainment Inc / Purple Innovation Inc / Pioneer Natural Resources Co / PayPal Holdings Inc / Restaurant Brands International Inc / Ring Energy Inc / Riley Exploration Permian Inc / Ranger Oil Corp / Repay Holdings Corp / Range Resources Corp / SilverBow Resources Inc / Shake Shack Inc / Snap One Holdings Corp / Virgin Galactic Holdings Inc / Block Inc / SS&C Technologies Holdings Inc / Latham Group Inc / Southwestern Energy Co / Carrols Restaurant Group Inc / Interface Inc / Tempur Sealy International Inc / Trex Company Inc / Tripadvisor Inc / TransUnion / Trivago NV / Texas Roadhouse Inc / Uber Technologies Inc / Udemy Inc / UnitedHealth Group Inc / Visa Inc / Vulcan Materials Co / Vornado Realty Trust / Viper Energy Partners LP / Verisk Analytics Inc / Viatris Inc / Wendys Co / WEX Inc / Wingstop Inc / Whiting Petroleum Corp / Western Union Co / Qualtrics International Inc / Exxon Mobil Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Jersey / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">INM-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">INM.O / OFSA3.SA / OGN / OILS.CD / ONPH.PK</td><td class="leftalignment">InMed Pharmaceuticals Inc / Ouro Fino Saude Animal Participacoes SA / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IPIX-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IPIX.PK / OFSA3.SA / OGN / OILS.CD / ONPH.PK</td><td class="leftalignment">Innovation Pharmaceuticals Inc / Ouro Fino Saude Animal Participacoes SA / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PCSA-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PCSA.O / OFSA3.SA / OGN / OILS.CD / ONPH.PK</td><td class="leftalignment">Processa Pharmaceuticals Inc / Ouro Fino Saude Animal Participacoes SA / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GTBP-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GTBP.O / OFSA3.SA / OGN / OILS.CD / ONPH.PK</td><td class="leftalignment">GT Biopharma Inc / Ouro Fino Saude Animal Participacoes SA / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">COGT-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">COGT.O / OFSA3.SA / OGN / OILS.CD / ONPH.PK</td><td class="leftalignment">Cogent Biosciences Inc / Ouro Fino Saude Animal Participacoes SA / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AVDL-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AVDL.O / OFSA3.SA / OGN / OILS.CD / ONPH.PK</td><td class="leftalignment">Avadel Pharmaceuticals PLC / Ouro Fino Saude Animal Participacoes SA / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN=US / AMRX=US / LLY=US / OGN / PFE=US / VTRS=US</td><td class="leftalignment">Amgen Inc / Amneal Pharmaceuticals Inc / Eli Lilly and Co / Organon & Co / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.6% Above Pre-Pandemic Base- Week 85</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Orogen Royalties Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">OGN.V</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ORGO-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ORGO.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Organogenesis Holdings Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">67421J108 / ABCB=US / ADS=US / AMGN=US / AMRX=US / AMT=US / AVAH=US / BTAI=US / BVH=US / CBRL=US / CCI=US / CMA=US / CMG=US / CONE=US / CUZ=US / DBRG=US / DENN=US / DIN=US / DRH=US / DRI=US / DT=US / EOG=US / FATE=US / FBK=US / FHN=US / GMED=US / HD=US / HGV=US / HIW=US / HTH=US / JACK=US / LLY=US / LOCO=US / LPLA=US / MA=US / MBIN=US / MCD=US / NDLS=US / NMTR=US / NUVA=US / OGN / OSMT=US / PB=US / PDM=US / PFE=US / PLAY=US / QSR=US / RLJ=US / ROIV=US / SBAC=US / SHAK=US / SIX=US / SNPO=US / SPLK=US / SPNE=US / SWCH=US / SWIM=US / TAST=US / TCBI=US / TNL=US / TXRH=US / UMPQ=US / VAC=US / VTRS=US / WAL=US / WEN=US / WH=US / WING=US / WMG=US / WTFC=US</td><td class="leftalignment">Oatly Group AB / Ameris Bancorp / Alliance Data Systems Corp / Amgen Inc / Amneal Pharmaceuticals Inc / American Tower Corp / Aveanna Healthcare Holdings Inc / BioXcel Therapeutics Inc / Bluegreen Vacations Holding Corp / Cracker Barrel Old Country Store Inc / Crown Castle International Corp / Comerica Inc / Chipotle Mexican Grill Inc / CyrusOne Inc / Cousins Properties Inc / DigitalBridge Group Inc / Denny's Corp / Dine Brands Global Inc / Diamondrock Hospitality Co / Darden Restaurants Inc / Dynatrace Inc / EOG Resources Inc / Fate Therapeutics Inc / FB Financial Corp / First Horizon Corp / Globus Medical Inc / Home Depot Inc / Hilton Grand Vacations Inc / Highwoods Properties Inc / Hilltop Holdings Inc / Jack in the Box Inc / Eli Lilly and Co / El Pollo Loco Holdings Inc / LPL Financial Holdings Inc / Mastercard Inc / Merchants Bancorp / McDonald's Corp / Noodles & Co / 9 Meters Biopharma Inc / NuVasive Inc / Organon & Co / Osmotica Pharmaceuticals PLC / Prosperity Bancshares Inc / Piedmont Office Realty Trust Inc / Pfizer Inc / Dave & Buster's Entertainment Inc / Restaurant Brands International Inc / RLJ Lodging Trust / Roivant Sciences Ltd / SBA Communications Corp / Shake Shack Inc / Six Flags Entertainment Corp / Snap One Holdings Corp / Splunk Inc / SeaSpine Holdings Corp / Switch Inc / Latham Group Inc / Carrols Restaurant Group Inc / Texas Capital Bancshares Inc / Travel + Leisure Co / Texas Roadhouse Inc / Umpqua Holdings Corp / Marriott Vacations Worldwide Corp / Viatris Inc / Western Alliance Bancorp / Wendys Co / Wyndham Hotels & Resorts Inc / Wingstop Inc / Warner Music Group Corp / Wintrust Financial Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN=US / AMRX=US / LLY=US / OGN / PFE=US / VTRS=US</td><td class="leftalignment">Amgen Inc / Amneal Pharmaceuticals Inc / Eli Lilly and Co / Organon & Co / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">11/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.9% Above Pre-Pandemic Base- Week 84</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">00770K202 / AMT=US / AMZN=US / ANGI=US / APP=US / ARRY=US / AUTL=US / BABA=US / BIIB=US / BKNG=US / BLL=US / BMY=US / CCK=US / CGEN=US / CLDT=US / CMPR=US / CVNA=US / DRH=US / ENR=US / EPC=US / EXPE=US / FB=US / FBHS=US / FLO=US / FTDR=US / GDDY=US / GDS=US / GMAB=US / GOOGL=US / H=US / HD=US / HOOK=US / HST=US / HYFM=US / INSE / IOVA=US / KRT=US / LEG=US / LOW=US / LYFT=US / MAPS=US / MHK=US / MNTV=US / MRK=US / MTCH=US / NGMS=US / NXPI=US / OGN / PEB=US / PGTI=US / PK=US / PRPL=US / PRVA=US / PSA=US / PTON=US / RHP=US / RLJ=US / RLMD=US / ROOT=US / SAFE=US / SFIX=US / SFT=US / SHO=US / SITC=US / SNAP=US / SQ=US / STRO=US / T=US / TCRR=US / TPX=US / TRIP=US / UBER=US / UTZ=US / VMEO=US / VRM=US / W=US / WH=US / WIX=US / WRE=US / XAIR=US</td><td class="leftalignment">Aemetis Inc / American Tower Corp / Amazon.com Inc / Angi Inc / Applovin Corp / Array Technologies Inc / Autolus Therapeutics PLC / Alibaba Group Holding Ltd / Biogen Inc / Booking Holdings Inc / Ball Corp / Bristol-Myers Squibb Co / Crown Holdings Inc / Compugen Ltd / Chatham Lodging Trust / Cimpress PLC / Carvana Co / Diamondrock Hospitality Co / Energizer Holdings Inc / Edgewell Personal Care Co / Expedia Group Inc / Meta Platforms Inc / Fortune Brands Home & Security Inc / Flowers Foods Inc / Frontdoor Inc / GoDaddy Inc / GDS Holdings Ltd / Genmab A/S / Alphabet Inc / Hyatt Hotels Corp / Home Depot Inc / HOOKIPA Pharma Inc / Host Hotels & Resorts Inc / Hydrofarm Holdings Group Inc / Inspired Entertainment Inc / Iovance Biotherapeutics Inc / Karat Packaging Inc / Leggett & Platt Inc / Lowe's Companies Inc / Lyft Inc / WM Technology Inc / Mohawk Industries Inc / Momentive Global Inc / Merck & Co Inc / Match Group Inc / NeoGames SA / NXP Semiconductors NV / Organon & Co / Pebblebrook Hotel Trust / PGT Innovations Inc / Park Hotels & Resorts Inc / Purple Innovation Inc / Privia Health Group Inc / Public Storage / Peloton Interactive Inc / Ryman Hospitality Properties Inc / RLJ Lodging Trust / Relmada Therapeutics Inc / Root Inc / Safehold Inc / Stitch Fix Inc / Shift Technologies Inc / Sunstone Hotel Investors Inc / Site Centers Corp / Snap Inc / Block Inc / Sutro Biopharma Inc / AT&T Inc / TCR2 Therapeutics Inc / Tempur Sealy International Inc / Tripadvisor Inc / Uber Technologies Inc / UTZ Brands Inc / Vimeo Inc / Vroom Inc / Wayfair Inc / Wyndham Hotels & Resorts Inc / Wix.Com Ltd / Washington Real Estate Investment Trust / Beyond Air Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / Ireland / Israel / Luxembourg / Netherlands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Organon : 3Q Takeaways: In-Line Results; Modestly Lowering 2022 Estimates as Opex Investments Ramp</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Ms. Ekaterina V. Knyazkova / Christopher Neyor</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Post-3Q model update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OGN</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Solid Quarter, And An Addition To The Pipeline; But We're Still Cautious</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">68622V106</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Organon : 3Q First Impressions: Another EBITDA Beat, Guidance Narrowed</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Ms. Ekaterina V. Knyazkova / Christopher Neyor</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Decent Q despite pandemic headwinds; Nexplanon returning to strong growth in 4Q</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">OGN</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Beat On Top And Bottom Line; 2021 Guidance Ranges Narrowed</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">OGN.N - Event Brief of Organon & Co conference call, Nov. 11, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">OGN.N - Event Transcript of Organon & Co conference call, Nov. 11, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Beat, Guidance Narrowed/Reiterated</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Vector Casa de Bolsa</td><td class="leftalignment">Noticias de empresas internacionales-11/11/2021</td><td class="leftalignment">Spanish</td><td class="rightalignment">1</td><td class="leftalignment">ATO@US / DIS@US / OGN@US / TPR@US</td><td class="leftalignment">Atmos Energy Corp / Walt Disney Co / Organon & Co / Tapestry Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COUNTRY-SPECIFIC / EQUITY / MARKET</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Laurentian Bank Securities</td><td class="leftalignment">Junior Precious Metal Royalty Companies</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">ELE=CA / OGN=CA / VOX=CA</td><td class="leftalignment">Elemental Royalties Corp / Orogen Royalties Inc / Vox Royalty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Industrial Materials / Metals & Minerals</td><td class="leftalignment">North America</td><td class="leftalignment">INDUSTRY OVERVIEW / INITIATING COVERAGE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Equity / INDUSTRY REPORTS</td><td class="leftalignment">Mr. Jacques Wortman</td></tr>
<tr class="odd"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 83</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">00770K202 / ABBV=US / ABNB=US / ADC=US / ADI=US / AMGN=US / AMK=US / AMRX=US / ANIP=US / APA=US / AR=US / BCEI=US / BIIB=US / BKNG=US / BMY=US / BNL=US / BRX=US / BWXT=US / CBRL=US / CDEV=US / CELU=US / CGEN=US / CLR=US / CMG=US / CNX=US / COP=US / CPE=US / CRK=US / CRSP=US / CRTO=US / CTRA=US / CUZ=US / CVX=US / DENN=US / DIN=US / DIOD=US / DRI=US / DVN=US / ENV=US / EOG=US / EPRT=US / EQT=US / ESTE=US / EXEL=US / EXPE=US / FANG=US / FATE=US / FIS=US / FISV=US / FOCS=US / GBT=US / GILD=US / GMAB=US / GNRC=US / GPOR=US / GPRE=US / GXO=US / HARP=US / HZO=US / INCY=US / IOVA=US / JACK=US / JELD=US / JRVR=US / KFRC=US / KO=US / LEG=US / LLY=US / LOCO=US / LPLA=US / MCD=US / MCFT=US / MCHP=US / MGNI=US / MGY=US / MRK=US / MRO=US / MTDR=US / MUR=US / NDLS=US / NOG=US / NSP=US / NXPI=US / NXTC=US / OAS=US / OGN / ON=US / OVV=US / OXY=US / PDCE=US / PFE=US / PLAY=US / PNTG=US / PSA=US / PXD=US / QSR=US / RCUS=US / REGI=US / REI=US / REPX=US / REX=US / RHP=US / ROCC=US / RRC=US / SBAC=US / SBOW=US / SCOR=US / SEIC=US / SHAK=US / SPG=US / SSNC=US / SWN=US / TAST=US / TCRR=US / TIL=US / TRIP=US / TRVG=US / TXN=US / TXRH=US / VNO=US / VNOM=US / VRNS=US / VTRS=US / WEN=US / WING=US / WIX=US / WLL=US / WLTW=US / WMB=US / XOM=US / ZI=US</td><td class="leftalignment">Aemetis Inc / Abbvie Inc / Airbnb Inc / Agree Realty Corp / Analog Devices Inc / Amgen Inc / AssetMark Financial Holdings Inc / Amneal Pharmaceuticals Inc / ANI Pharmaceuticals Inc / APA Corp (US) / Antero Resources Corp / Civitas Resources Inc / Biogen Inc / Booking Holdings Inc / Bristol-Myers Squibb Co / Bunzl plc / Brixmor Property Group Inc / BWX Technologies Inc / Cracker Barrel Old Country Store Inc / Centennial Resource Development Inc / Celularity Inc / Compugen Ltd / Continental Resources Inc / Chipotle Mexican Grill Inc / CNX Resources Corp / Conocophillips / Callon Petroleum Co / Comstock Resources Inc / CRISPR Therapeutics AG / Criteo SA / Coterra Energy Inc / Cousins Properties Inc / Chevron Corp / Denny's Corp / Dine Brands Global Inc / Diodes Inc / Darden Restaurants Inc / Devon Energy Corp / Envestnet Inc / EOG Resources Inc / Essential Properties Realty Trust Inc / EQT Corp / Earthstone Energy Inc / Exelixis Inc / Expedia Group Inc / Diamondback Energy Inc / Fate Therapeutics Inc / Fidelity National Information Services Inc / Fiserv Inc / Focus Financial Partners Inc / Global Blood Therapeutics Inc / Gilead Sciences Inc / Genmab A/S / Generac Holdings Inc / Gulfport Energy Corp / Green Plains Inc / GXO Logistics Inc / Harpoon Therapeutics Inc / MarineMax Inc / Incyte Corp / Iovance Biotherapeutics Inc / Jack in the Box Inc / JELD-WEN Holding Inc / James River Group Holdings Ltd / Kforce Inc / Coca-Cola Co / Leggett & Platt Inc / Eli Lilly and Co / El Pollo Loco Holdings Inc / LPL Financial Holdings Inc / McDonald's Corp / Mastercraft Boat Holdings Inc / Microchip Technology Inc / Magnite Inc / Magnolia Oil & Gas Corp / Merck & Co Inc / Marathon Oil Corp / Matador Resources Co / Murphy Oil Corp / Noodles & Co / Northern Oil and Gas Inc / Insperity Inc / NXP Semiconductors NV / NextCure Inc / Oasis Petroleum Inc / Organon & Co / ON Semiconductor Corp / Ovintiv Inc / Occidental Petroleum Corp / PDC Energy Inc / Pfizer Inc / Dave & Buster's Entertainment Inc / Pennant Group Inc / Public Storage / Pioneer Natural Resources Co / Restaurant Brands International Inc / Arcus Biosciences Inc / Renewable Energy Group Inc / Ring Energy Inc / Riley Exploration Permian Inc / REX American Resources Corp / Ryman Hospitality Properties Inc / Ranger Oil Corp / Range Resources Corp / SBA Communications Corp / SilverBow Resources Inc / Comscore Inc / SEI Investments Co / Shake Shack Inc / Simon Property Group Inc / SS&C Technologies Holdings Inc / Southwestern Energy Co / Carrols Restaurant Group Inc / TCR2 Therapeutics Inc / Instil Bio Inc / Tripadvisor Inc / Trivago NV / Texas Instruments Inc / Texas Roadhouse Inc / Vornado Realty Trust / Viper Energy Partners LP / Varonis Systems Inc / Viatris Inc / Wendys Co / Wingstop Inc / Wix.Com Ltd / Whiting Petroleum Corp / Willis Towers Watson PLC / Williams Companies Inc / Exxon Mobil Corp / ZoomInfo Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / France / Ireland / Israel / Netherlands / Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN=US / AMRX=US / LLY=US / OGN / PFE=US / VTRS=US</td><td class="leftalignment">Amgen Inc / Amneal Pharmaceuticals Inc / Eli Lilly and Co / Organon & Co / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">TAK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">TAK / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PHIO-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PHIO.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Phio Pharmaceuticals Corp / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ATXI-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ATXI.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Avenue Therapeutics Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RZLT-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">RZLT.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Rezolute Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MBRX-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MBRX.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Moleculin Biotech Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ODT-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SCPH-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SCPH.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">scPharmaceuticals Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EQ-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">EQ.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Equillium Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MDGL-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MDGL.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Madrigal Pharmaceuticals Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALLK-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ALLK.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Allakos Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Exploration Companies Investors Should Take a Look at</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">OR.TO / ABX.TO / ALS.TO / AMZ.V / DEX.V / MD.V / OGN.V / PAAS.TO / RGLD.OQ / WPM.TO</td><td class="leftalignment">Osisko Gold Royalties Ltd / Barrick Gold Corp / Altius Minerals Corp / Azucar Minerals Ltd / Almadex Minerals Ltd / Midland Exploration Inc / Orogen Royalties Inc / Pan American Silver Corp / Royal Gold Inc / Wheaton Precious Metals Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / SECTOR</td><td class="leftalignment">COMMODITY RESEARCH / INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="odd"><td class="leftalignment">10/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.3% Above Pre-Pandemic Base- Week 81</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Organon & Co</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IPIX-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IPIX.PK / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Innovation Pharmaceuticals Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BE0165385973 / CA0585861085 / CA0977512007 / CA50202P1053 / CA9609083097 / FR0000054470 / GB00BMVP7Y09 / GB00BZ09BD16 / HEI.N / IL0010824113 / IL0011571556 / IL0011786154 / IL0011794802 / IL0011796625 / JE00B783TY65 / JP3435000009 / LU2314763264 / MOGa / NL0010696654 / US00091E1091 / US00152K1016 / US00287Y1091 / US00507V1098 / US0079031078 / US00810F1066 / US0123481089 / US01671P1003 / US01741R1023 / US03027X1000 / US03044L1052 / US0311621009 / US03236M2008 / US0382221051 / US03828A1016 / US04523Y1055 / US0463531089 / US07725L1026 / US09062W2044 / US0970231058 / US0997241064 / US1095041000 / US1101221083 / US1167941087 / US1442851036 / US1567271093 / US18915M1071 / US1920051067 / US22041X1028 / US22788C1053 / US22822V1017 / US2297901009 / US23355L1061 / US2358511028 / US23954D1090 / US2575541055 / US28414H1032 / US28489L1044 / US2855121099 / US29082A1079 / US29414B1044 / US29664W1053 / US30049H1023 / US30050B1017 / US33813J1060 / US34631B1017 / US34959E1091 / US3695501086 / US3696043013 / US37733W1053 / US38246G1085 / US4228061093 / US4282911084 / US4385161066 / US4432011082 / US4464131063 / US4523271090 / US45254E1073 / US4781601046 / US49926T1043 / US5024311095 / US5128071082 / US5218652049 / US5324571083 / US5398301094 / US55306N1046 / US58933Y1055 / US5949181045 / US60468T1051 / US6098391054 / US63009R1095 / US6541101050 / US6668071029 / US66987V1098 / US6701002056 / US67080N1019 / US68622V1061 / US69404D1081 / US6974351057 / US7170811035 / US72815L1070 / US72919P2020 / US7475251036 / US75340L1044 / US75513E1010 / US75943R1023 / US7711951043 / US78410G1040 / US80105N1054 / US81578P1066 / US81730H1095 / US81762P1021 / US8334451098 / US8356993076 / US8485741099 / US85205L1070 / US8740541094 / US88025U1097 / US88160R1014 / US8835561023 / US8852601090 / US8936411003 / US8968181011 / US90089L1089 / US90138F1021 / US90184D1000 / US90240B1061 / US90364P1057 / US91307C1027 / US9222801022 / US92336X1090 / US92343X1000 / US92839U2069 / US9807451037 / US98138J2069 / US98936J1016 / US98978V1035 / US98980G1022 / US98986T1088</td><td class="leftalignment">Melexis NV / Ballard Power Systems Inc / Bombardier Inc / Li-Cycle Holdings Corp / Westport Fuel Systems Inc / Ubisoft Entertainment SA / Royalty Pharma PLC / Atlassian Corporation PLC / HEICO Corp / Check Point Software Technologies Ltd / Tufin Software Technologies Ltd / REE Automotive Ltd / Cellebrite DI Ltd / Arbe Robotics Ltd / Aptiv PLC / Sony Group Corp / Arrival SA / Moog Inc / Uniqure NV / Absci Corp / AKA Brands Holding Corp / Abbvie Inc / Activision Blizzard Inc / Advanced Micro Devices Inc / AerSale Corp / Albany International Corp / Allakos Inc / Allegheny Technologies Inc / American Tower Corp / American Well Corp / Amgen Inc / Amyris Inc / Applied Materials Inc / Applied Therapeutics Inc / Aspen Aerogels Inc / AstraZeneca PLC / Beigene Ltd / BioLife Solutions Inc / Boeing Co / Borgwarner Inc / Brilliant Earth Group Inc / Bristol-Myers Squibb Co / Bruker Corp / Carpenter Technology Corp / Cerence Inc / Cloudflare Inc / Codexis Inc / Corsair Gaming Inc / CrowdStrike Holdings Inc / Crown Castle International Corp / Cue Health Inc / DXC Technology Co / Danaher Corp / Day One Biopharmaceuticals Inc / Domo Inc / Elanco Animal Health Inc / Electric Last Mile Solutions Inc / Electronic Arts Inc / Embraer SA / Epam Systems Inc / Esperion Therapeutics Inc / Evolv Technologies Holdings Inc / Evolent Health Inc / Fisker Inc / ForgeRock Inc / Fortinet Inc / General Dynamics Corp / General Electric Co / GlaxoSmithKline PLC / Goodrx Holdings Inc / HEICO Corp / Hexcel Corp / Honeywell International Inc / Howmet Aerospace Inc / Huntington Ingalls Industries Inc / Illumina Inc / Immuneering Corp / Johnson & Johnson / Knowbe4 Inc / L3harris Technologies Inc / Lam Research Corp / Lear Corp / Eli Lilly and Co / Lockheed Martin Corp / MKS Instruments Inc / Merck & Co Inc / Microsoft Corp / Mirati Therapeutics Inc / Monolithic Power Systems Inc / NanoString Technologies Inc / Nikola Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Nuvation Bio Inc / Organon & Co / Pacific Biosciences of California Inc / Palo Alto Networks Inc / Pfizer Inc / Playtika Holding Corp / Plug Power Inc / Qualcomm Inc / Rapid Micro Biosystems Inc / Raytheon Technologies Corp / Relay Therapeutics Inc / Roche Holding AG / SBA Communications Corp / Sanofi SA / Seer Inc / SentinelOne Inc / ServiceNow Inc / Snowflake Inc. / Sony Group Corp / Spirit AeroSystems Holdings Inc / SpringWorks Therapeutics Inc / Take-Two Interactive Software Inc / 10X Genomics Inc / Tesla Inc / Thermo Fisher Scientific Inc / Thorne Healthtech Inc / TransDigm Group Inc / Triumph Group Inc / TuSimple Holdings Inc / Twilio Inc / Twist Bioscience Corp / Tyra Biosciences Inc / UiPath Inc / United Therapeutics Corp / Varonis Systems Inc / Veoneer Inc / Verint Systems Inc / Visteon Corp / Woodward Inc / Workhorse Group Inc / Zendesk Inc / Zoetis Inc / Zscaler Inc / Zynga Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Cayman Islands / Denmark / France / Israel / Japan / Jersey / Luxembourg / Netherlands / Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / GB00BMVP7Y09 / US1101221083 / US28414H1032 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054 / US98978V1035</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Royalty Pharma PLC / Bristol-Myers Squibb Co / Elanco Animal Health Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA / Zoetis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.1% Above Pre-Pandemic Base- Week 80</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HROW-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HROW.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Harrow Health Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">TAK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">TAK / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.0% Above Pre-Pandemic Base- Week 79</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Laurentian Bank Securities</td><td class="leftalignment">Mining Watch List — October 2021</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">AGC=CA / ANX=CA / AZM=CA / BNKR=CA / ELE=CA / GFG=CA / GOLD=CA / GSVR=CA / KLD=CA / LKY=CA / LSX=CA / ME=CA / MTT=CA / MTU=CA / MZN=CA / OGN=CA / PRYM=CA / QCX=CA / RDG=CA / ROCK=CA / STE=CA / TML=CA / VOX=CA</td><td class="leftalignment">Amarillo Gold Corp / Anaconda Mining Inc / Azimut Exploration Inc / Bunker Hill Mining Corp / Elemental Royalties Corp / GFG Resources Inc / GoldMining Inc / Guanajuato Silver Company Ltd / Kenorland Minerals Ltd / Lucky Minerals Inc / Lasalle Exploration Corp / Moneta Gold Inc / Magna Terra Minerals Inc / Manitou Gold Inc / Metallum Resources Inc / Orogen Royalties Inc / Prime Mining Corp / QcX Gold Corp / Ridgeline Minerals Corp / Rockridge Resources Ltd / Starr Peak Mining Ltd / Treasury Metals Inc / Vox Royalty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Industrial Materials / Metals & Minerals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Mr. Barry D. Allan / Mr. Ryan Hanley / Mr. Jacques Wortman</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Initiating At Neutral: Current Asset Mix Gives Us Pause</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">68622V106 / 00287Y109 / 031162100 / 03168L105 / 071734107 / 09062X103 / 216648402 / 30048L104 / 58933Y105 / 717081103 / 75886F107 / 881624209 / 92556V106 / G30401106 / G97822103</td><td class="leftalignment">Organon & Co / Abbvie Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Bausch Health Companies Inc / Biogen Inc / Cooper Companies Inc / Evofem Biosciences Inc / Merck & Co Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Viatris Inc / Endo International PLC / Perrigo Company PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">00770K202 / AMGN=US / AMRX=US / APPN=US / ARCB=US / AWI=US / BIIB=US / CBRL=US / CGEN=US / CMG=US / CRMD.US / DENN=US / DIN=US / DRI=US / ESTE=US / FEYE=US / GPRE=US / JACK=US / KRT=US / LLY=US / LOCO=US / MCD=US / MDT=US / MHK=US / MRK=US / NDLS=US / NUVA=US / OGN / OPT=US / PATH=US / PCRX=US / PFE=US / PLAY=US / QSR=US / REGI=US / REX=US / SAGE=US / SHAK=US / TAST=US / TILE=US / VTRS=US / WEN=US / WING=US</td><td class="leftalignment">Aemetis Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Appian Corp / ArcBest Corp / Armstrong World Industries Inc / Biogen Inc / Cracker Barrel Old Country Store Inc / Compugen Ltd / Chipotle Mexican Grill Inc / CorMedix Inc / Denny's Corp / Dine Brands Global Inc / Darden Restaurants Inc / Earthstone Energy Inc / Mandiant Inc / Green Plains Inc / Jack in the Box Inc / Karat Packaging Inc / Eli Lilly and Co / El Pollo Loco Holdings Inc / McDonald's Corp / Medtronic PLC / Mohawk Industries Inc / Merck & Co Inc / Noodles & Co / NuVasive Inc / Organon & Co / Opthea Ltd / UiPath Inc / Pacira Biosciences Inc / Pfizer Inc / Dave & Buster's Entertainment Inc / Restaurant Brands International Inc / Renewable Energy Group Inc / REX American Resources Corp / SAGE Therapeutics Inc / Shake Shack Inc / Carrols Restaurant Group Inc / Interface Inc / Viatris Inc / Wendys Co / Wingstop Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Australasia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AMGN=US / AMRX=US / LLY=US / MRK=US / OGN / PFE=US / VTRS=US</td><td class="leftalignment">Amgen Inc / Amneal Pharmaceuticals Inc / Eli Lilly and Co / Merck & Co Inc / Organon & Co / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Differentiated Strategy, Solid Management, But Stock A Wait And See</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.6% Above Pre-Pandemic Base- Week 78</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for OGN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">68622V106</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">CEOs Impress Up Close: Growth and Balance; Street Strength</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALS.TO / ABX.TO / ANGJ.J / ARCC.OQ / FNV.TO / FR.TO / FVI.TO / KL.TO / LRA.V / MD.V / NEM.N / OGN.V / OR.TO / PAAS.TO / VALE3.SA / WPM.TO</td><td class="leftalignment">Altius Minerals Corp / Barrick Gold Corp / AngloGold Ashanti Ltd / Ares Capital Corp / Franco-Nevada Corp / First Majestic Silver Corp / Fortuna Silver Mines Inc / Kirkland Lake Gold Ltd / Lara Exploration Ltd / Midland Exploration Inc / Newmont Corporation / Orogen Royalties Inc / Osisko Gold Royalties Ltd / Pan American Silver Corp / Vale SA / Wheaton Precious Metals Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / South Africa / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Africa / Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / SECTOR</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 27 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BE0165385973 / CA0089118776 / CA0585861085 / CA1363751027 / CA13645T1003 / CA50202P1053 / CA87241L1094 / CA9609083097 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / IL0011786154 / JE00B783TY65 / JP3435000009 / LU2314763264 / NL0000687663 / NL0010273215 / PAP310761054 / US00287Y1091 / US00404A1097 / US00857U1079 / US00912X3026 / US00922R1059 / US0116591092 / US01625V1044 / US01748X1028 / US0234361089 / US02376R1023 / US0367521038 / US03937C1053 / US0463531089 / US0491642056 / US0997241064 / US10920V1070 / US1101221083 / US12541W2098 / US1255231003 / US1264081035 / US13781Y1038 / US14171W1036 / US15135B1017 / US1567271093 / US18914F1030 / US21240E1055 / US22284P1057 / US23753F1075 / US23918K1088 / US2473617023 / US26142R1041 / US28414H1032 / US28489L1044 / US28623U1016 / US3021301094 / US31428X1063 / US33813J1060 / US37733W1053 / US40412C1018 / US4198791018 / US4433201062 / US4448591028 / US4456581077 / US45784A1043 / US4771431016 / US4781601046 / US4990491049 / US50187A1079 / US5150981018 / US5218652049 / US53228F1012 / US5324571083 / US55406W1036 / US58933Y1055 / US5904791358 / US60855R1005 / US6541101050 / US6558441084 / US66987V1098 / US6701002056 / US67181A1079 / US6795801009 / US68622V1061 / US6877931096 / US7170811035 / US72919P2020 / US74276R1023 / US74967X1037 / US75025X1000 / US7711951043 / US78709Y1055 / US80105N1054 / US80689H1023 / US82671G1004 / US8308791024 / US8356993076 / US8447411088 / US8485771021 / US86881A1007 / US88160R1014 / US90089L1089 / US9029251066 / US9078181081 / US9100471096 / US9113121068 / US91324P1021 / US9139031002 / US92336X1090 / US92337R1014 / US92839U2069 / US9507551086 / US98138J2069 / US9837931008 / US98978V1035</td><td class="leftalignment">Melexis NV / Air Canada / Ballard Power Systems Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Li-Cycle Holdings Corp / TFI International Inc / Westport Fuel Systems Inc / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / REE Automotive Ltd / Aptiv PLC / Sony Group Corp / Arrival SA / AerCap Holdings NV / ASML Holding NV / Copa Holdings SA / Abbvie Inc / Acadia Healthcare Company Inc / agilon health Inc / Air Lease Corp / Air Transport Services Group Inc / Alaska Air Group Inc / Alignment Healthcare Inc / Allegiant Travel Co / Amedisys Inc / American Airlines Group Inc / Anthem Inc / ArcBest Corp / AstraZeneca PLC / Atlas Air Worldwide Holdings Inc / Borgwarner Inc / Bright Health Group Inc / Bristol-Myers Squibb Co / CH Robinson Worldwide Inc / Cigna Corp / CSX Corp / Cano Health Inc / CareMax Inc / Centene Corp / Cerence Inc / Clover Health Investments Corp / Controladora Vuela Compania de Aviacion SAB de CV / Covenant Logistics Group Inc / Daseke Inc / DaVita Inc / Delta Air Lines Inc / DraftKings Inc / Elanco Animal Health Inc / Electric Last Mile Solutions Inc / Elevation Oncology Inc / Expeditors International of Washington Inc / FedEx Corp / Fisker Inc / GlaxoSmithKline PLC / HCA Healthcare Inc / Hawaiian Holdings Inc / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / InnovAge Holding Corp / JetBlue Airways Corp / Johnson & Johnson / Knight-Swift Transportation Holdings Inc / LHC Group Inc / Landstar System Inc / Lear Corp / Lifestance Health Group Inc / Eli Lilly and Co / MYT Netherlands Parent BV / Merck & Co Inc / Mesa Air Group Inc / Molina Healthcare Inc / Nikola Corp / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Oak Street Health Inc / Old Dominion Freight Line Inc / Organon & Co / Oscar Health Inc / Pfizer Inc / Plug Power Inc / Privia Health Group Inc / RH / Radiant Logistics Inc / Roche Holding AG / Saia Inc / Sanofi SA / Schneider National Inc / Signify Health Inc / SkyWest Inc / Sony Group Corp / Southwest Airlines Co / Spirit Airlines Inc / Surgery Partners Inc / Tesla Inc / TuSimple Holdings Inc / USA Truck Inc / Union Pacific Corp / United Airlines Holdings Inc / United Parcel Service Inc / UnitedHealth Group Inc / Universal Health Services Inc / Veoneer Inc / Vera Therapeutics Inc / Visteon Corp / Werner Enterprises Inc / Workhorse Group Inc / XPO Logistics Inc / Zoetis Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Denmark / France / Japan / Jersey / Luxembourg / Mexico / Netherlands / Panama / Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.2% Above Pre-Pandemic Base- Week 77</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Remain Stable Amidst Delta - Week 76</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">OGN.N - Event Transcript of Organon & Co conference call, Sep. 13, 2021 / 9:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 75</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Japan / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CA0089118776 / CH0012005267 / CH0012032048 / DE0006969603 / DE000A0DJ6J9 / DE000A1EWWW0 / DK0060534915 / FR0000054470 / FR0000120578 / GB0009252882 / GB0009895292 / JE00B783TY65 / PAP310761054 / US00287Y1091 / US00507V1098 / US00653A1079 / US0116591092 / US01748X1028 / US02376R1023 / US02875D1090 / US03073E1055 / US0311621009 / US04271T1007 / US0463531089 / US09061G1013 / US09062X1037 / US1101221083 / US1220171060 / US1241551027 / US1311931042 / US1314761032 / US14149Y1082 / US1985161066 / US21240E1055 / US2435371073 / US2473617023 / US2533931026 / US26142R1041 / US2855121099 / US29089Q1058 / US30260D1037 / US30320C1036 / US31620M1062 / US3377381088 / US3448491049 / US3755581036 / US37733W1053 / US37940X1028 / US4103451021 / US41068X1000 / US4198791018 / US45337C1027 / US4771431016 / US5324571083 / US5500211090 / US58155Q1031 / US58933Y1055 / US5904791358 / US6541061031 / US66987V1098 / US6701002056 / US68622V1061 / US6936561009 / US7170811035 / US7512121010 / US7711951043 / US7782961038 / US80105N1054 / US82489W1071 / US8305661055 / US8308791024 / US83417M1045 / US8447411088 / US8485771021 / US85916J4094 / US8725401090 / US8740541094 / US89377M1099 / US9043111072 / US9100471096 / US9182041080 / US98585X1046 / US98986T1088 / VGG312491084</td><td class="leftalignment">Air Canada / Novartis AG / Roche Holding AG / Puma SE / SMA Solar Technology AG / Adidas AG / Novo Nordisk A/S / Ubisoft Entertainment SA / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Aptiv PLC / Copa Holdings SA / Abbvie Inc / Activision Blizzard Inc / Adaptimmune Therapeutics PLC / Alaska Air Group Inc / Allegiant Travel Co / American Airlines Group Inc / American Outdoor Brands Inc / Amerisourcebergen Corp / Amgen Inc / Array Technologies Inc / AstraZeneca PLC / Biomarin Pharmaceutical Inc / Biogen Inc / Bristol-Myers Squibb Co / Burlington Stores Inc / Butterfly Network Inc / Callaway Golf Co / Calumet Specialty Products Partners LP / Cardinal Health Inc / Columbia Sportswear Co / Controladora Vuela Compania de Aviacion SAB de CV / Deckers Outdoor Corp / Delta Air Lines Inc / DICK'S Sporting Goods Inc / DraftKings Inc / Electronic Arts Inc / Emergent BioSolutions Inc / Figs Inc / FTC Solar Inc / Fidelity National Information Services Inc / Fiserv Inc / Foot Locker Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Global Payments Inc / HanesBrands Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Hawaiian Holdings Inc / Incyte Corp / JetBlue Airways Corp / Eli Lilly and Co / Lululemon Athletica Inc / Mckesson Corp / Merck & Co Inc / Mesa Air Group Inc / Nike Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / PVH Corp / Pfizer Inc / Ralph Lauren Corp / Roche Holding AG / Ross Stores Inc / Sanofi SA / Shoals Technologies Group Inc / Skechers USA Inc / SkyWest Inc / Solaredge Technologies Inc / Southwest Airlines Co / Spirit Airlines Inc / Stereotaxis Inc / TJX Companies Inc / Take-Two Interactive Software Inc / Transmedics Group Inc / Under Armour Inc / United Airlines Holdings Inc / VF Corp / Yeti Holdings Inc / Zynga Inc / Establishment Labs Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / France / Germany / Jersey / Mexico / Panama / Switzerland / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">09/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 74</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/04/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Orogen Royalties Inc</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">OGN.V</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Organon & Co</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 30 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AU000000LYC6 / CA0089118776 / CA53680Q2071 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / KYG4740B1059 / NL0010273215 / PAP310761054 / SE0009414576 / US00287Y1091 / US0079731008 / US0116591092 / US0126531013 / US01748X1028 / US02376R1023 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US21240E1055 / US2473617023 / US3463751087 / US37733W1053 / US4198791018 / US4771431016 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US53814L1089 / US55306N1046 / US5533681012 / US58406B1035 / US58933Y1055 / US5904791358 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054 / US8308791024 / US8447411088 / US8485771021 / US8807701029 / US90385V1070 / US9100471096 / US91347P1057</td><td class="leftalignment">Lynas Rare Earths Ltd / Air Canada / Lithium Americas Corp / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Ichor Holdings Ltd / ASML Holding NV / Copa Holdings SA / Oncopeptides AB / Abbvie Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / Albemarle Corp / Allegiant Travel Co / American Airlines Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / Controladora Vuela Compania de Aviacion SAB de CV / Delta Air Lines Inc / FormFactor Inc / GlaxoSmithKline PLC / Hawaiian Holdings Inc / JetBlue Airways Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / Livent Corp / MKS Instruments Inc / Mp Materials Corp / MedAvail Holdings Inc / Merck & Co Inc / Mesa Air Group Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA / SkyWest Inc / Southwest Airlines Co / Spirit Airlines Inc / Teradyne Inc / Ultra Clean Holdings Inc / United Airlines Holdings Inc / Universal Display Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Cayman Islands / Denmark / France / Mexico / Netherlands / Panama / Sweden / Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Australasia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">08/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 73</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Orogen Shows Its Flexibility, Moving Ahead on Many Fronts</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">OGN.V / ALS.TO / GAIN.OQ / MD.V</td><td class="leftalignment">Orogen Royalties Inc / Altius Minerals Corp / Gladstone Investment Corp / Midland Exploration Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / SECTOR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="even"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.3% Above Pre-Pandemic Base- Week 72</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Organon & Co: 1 director</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="even"><td class="leftalignment">08/18/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Royalty Companies Report Record Revenues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">WPM.TO / ABX.TO / FNV.TO / FVI.TO / LRA.V / MD.V / OGN.V / OR.TO / PAAS.TO / REO.CD</td><td class="leftalignment">Wheaton Precious Metals Corp / Barrick Gold Corp / Franco-Nevada Corp / Fortuna Silver Mines Inc / Lara Exploration Ltd / Midland Exploration Inc / Orogen Royalties Inc / Osisko Gold Royalties Ltd / Pan American Silver Corp / Reservoir Capital Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / SECTOR</td><td class="leftalignment">COMMODITY RESEARCH / INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Beat Top And Bottom Line; 2021 Guidance Reiterated</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">00770K202 / ABNB=US / AEL=US / APLT=US / AVB=US / AZEK=US / BKI=US / CACI=US / CHH=US / CRMD.US / CVNA=US / DASH=US / DCO=US / DIS=US / EVRI=US / FLO=US / FNF=US / GMAB=US / H=US / HLT=US / HYFM=US / INSE / KRT=US / MAR=US / NGMS=US / NMTR=US / OGN / PENN=US / PGTI=US / REPX=US / RLJ=US / ROOT=US / TAST=US / TREX=US / UTZ=US / WH=US</td><td class="leftalignment">Aemetis Inc / Airbnb Inc / American Equity Investment Life Holding Co / Applied Therapeutics Inc / Avalonbay Communities Inc / Azek Company Inc / Black Knight Inc / CACI International Inc / Choice Hotels International Inc / CorMedix Inc / Carvana Co / DoorDash Inc / Ducommun Inc / Walt Disney Co / Everi Holdings Inc / Flowers Foods Inc / Fidelity National Financial Inc / Genmab A/S / Hyatt Hotels Corp / Hilton Worldwide Holdings Inc / Hydrofarm Holdings Group Inc / Inspired Entertainment Inc / Karat Packaging Inc / Marriott International Inc / NeoGames SA / 9 Meters Biopharma Inc / Organon & Co / Penn National Gaming Inc / PGT Innovations Inc / Riley Exploration Permian Inc / RLJ Lodging Trust / Root Inc / Carrols Restaurant Group Inc / Trex Company Inc / UTZ Brands Inc / Wyndham Hotels & Resorts Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Organon : Strong Start - Raising Estimates</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Ms. Ekaterina V. Knyazkova / Christopher Neyor</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Solid first quarter and attractive dividend yield; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OGN</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">first earnings call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Organon : 2Q First Impressions: Solid First Qtr Post Spin with Sales and Margins Ahead of our Estimates</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Ms. Ekaterina V. Knyazkova / Christopher Neyor</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Vector Casa de Bolsa</td><td class="leftalignment">Noticias de empresas internacionales-08/12/2021</td><td class="leftalignment">Spanish</td><td class="rightalignment">1</td><td class="leftalignment">BIDU@US / BR@US / EBAY@US / OGN@US</td><td class="leftalignment">Baidu Inc / Broadridge Financial Solutions Inc / eBay Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COUNTRY-SPECIFIC / EQUITY / MARKET</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">OGN.N - Event Brief of Organon & Co conference call, Aug. 12, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">OGN.N - Event Transcript of Organon & Co conference call, Aug. 12, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 EPS, Revenue Beat Expectations; 2021 Guidance Reiterated</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">HY Healthcare Check-Up : Wednesday, August 11 Roundup</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MPLN.N / OGN.N</td><td class="leftalignment">Multiplan Corp / Organon & Co</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS</td><td class="leftalignment">David Common / Mr. Bradley H. Cobb</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">CH0012005267 / CH0012032048 / DE0006231004 / DK0060534915 / FR0000120578 / GB0009252882 / GB0009895292 / GB00BMVP7Y09 / IE00BKVD2N49 / KYG037AX1015 / KYG4740B1059 / LGFa / LGFb / NL0000226223 / NL0010273215 / US00164V1035 / US00287Y1091 / US0079031078 / US0090661010 / US0378331005 / US0382221051 / US0463531089 / US09857L1089 / US1101221083 / US11135F1012 / US1572101053 / US1727551004 / US1985161066 / US2435371073 / US2546871060 / US25470F1049 / US25470F3029 / US30049H1023 / US30212P3038 / US30260D1037 / US35137L1052 / US37733W1053 / US43300A2033 / US4485791028 / US4581401001 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US5500211090 / US55306N1046 / US55405Y1001 / US5719032022 / US5738741041 / US58933Y1055 / US5951121038 / US6098391054 / US6541061031 / US6549022043 / US66987V1098 / US6701002056 / US67066G1040 / US68622V1061 / US69120X1072 / US70614W1009 / US7170811035 / US7392761034 / US74736K1016 / US7475251036 / US7711951043 / US80105N1054 / US81730H1095 / US82706C1080 / US83088M1027 / US8610121027 / US8807701029 / US89142B1070 / US89677Q1076 / US89686D1054 / US8969452015 / US9043111072 / US92556H2067 / US9282981086 / US9581021055 / US98585X1046 / VGG273581030</td><td class="leftalignment">Novartis AG / Roche Holding AG / Infineon Technologies AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Royalty Pharma PLC / Seagate Technology Holdings PLC / Ambarella Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Lions Gate Entertainment Corp / STMicroelectronics NV / ASML Holding NV / AMC Networks Inc / Abbvie Inc / Advanced Micro Devices Inc / Airbnb Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Booking Holdings Inc / Bristol-Myers Squibb Co / Broadcom Inc / CEVA Inc / Cirrus Logic Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Walt Disney Co / Discovery Inc / Discovery Inc / Evolv Technologies Holdings Inc / Expedia Group Inc / Figs Inc / Fox Corp / GlaxoSmithKline PLC / Hilton Worldwide Holdings Inc / Hyatt Hotels Corp / Intel Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / Lululemon Athletica Inc / MKS Instruments Inc / MACOM Technology Solutions Holdings Inc / Marriott International Inc / Marvell Technology Inc / Merck & Co Inc / Micron Technology Inc / Monolithic Power Systems Inc / Nike Inc / Nokia Oyj / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Organon & Co / Owlet Inc / Peloton Interactive Inc / Pfizer Inc / Power Integrations Inc / Qorvo Inc / Qualcomm Inc / Roche Holding AG / Sanofi SA / SentinelOne Inc / Silicon Motion Technology Corp / Skyworks Solutions Inc / STMicroelectronics NV / Teradyne Inc / Torrid Holdings Inc / Trip.com Group Ltd / Trivago NV / Tripadvisor Inc / Under Armour Inc / ViacomCBS Inc / Vishay Intertechnology Inc / Western Digital Corp / Yeti Holdings Inc / Despegar.com Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / Finland / France / Germany / Ireland / Netherlands / Switzerland / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">00770K202 / 45665G303 / AAN=US / ABG=US / ADI=US / AEL=US / AIN / AJG=US / AJRD=US / AMD=US / AMGN=US / APH=US / ATVI=US / AWI=US / BCEI=US / BIGC=US / BL=US / BRO=US / BSX=US / BXP=US / BYD=US / CEQP=US / CNC=US / CSGP=US / DLR=US / EEFT=US / EFX=US / EGP=US / EHC=US / ENPH=US / EPR=US / EQH=US / EQR=US / EXR=US / FFIN=US / FISV=US / FIVN=US / FNF=US / GDDY=US / GDS=US / GOOGL=US / GPRE=US / HIW=US / HTH=US / HXL=US / IBTX=US / IQV=US / KFY=US / MA=US / MANH=US / MAT=US / MEDP=US / MPWR-US / MRO=US / MTDR=US / NXPI=US / NXRT=US / OGN / OVV=US / PDCE=US / PII=US / RDFN=US / REGI=US / REX=US / RLMD=US / RNST=US / SPOT=US / SSTK=US / ST=US / SWN=US / SYK=US / TDOC=US / TEL=US / TENB=US / TRU=US / TSHA / V=US / WLTW=US / WU=US / XLNX=US / ZG=US</td><td class="leftalignment">Aemetis Inc / Infinity Pharmaceuticals Inc / Aaron's Company Inc / Asbury Automotive Group Inc / Analog Devices Inc / American Equity Investment Life Holding Co / Albany International Corp / Arthur J Gallagher & Co / Aerojet Rocketdyne Holdings Inc / Advanced Micro Devices Inc / Amgen Inc / Amphenol Corp / Activision Blizzard Inc / Armstrong World Industries Inc / Civitas Resources Inc / Bigcommerce Holdings Inc / Blackline Inc / Brown & Brown Inc / Boston Scientific Corp / Boston Properties Inc / Boyd Gaming Corp / Crestwood Equity Partners LP / Centene Corp / CoStar Group Inc / Digital Realty Trust Inc / Euronet Worldwide Inc / Equifax Inc / Eastgroup Properties Inc / Encompass Health Corp / Enphase Energy Inc / EPR Properties / Equitable Holdings Inc / Equity Residential / Extra Space Storage Inc / First Financial Bankshares Inc / Fiserv Inc / Five9 Inc / Fidelity National Financial Inc / GoDaddy Inc / GDS Holdings Ltd / Alphabet Inc / Green Plains Inc / Highwoods Properties Inc / Hilltop Holdings Inc / Hexcel Corp / Independent Bank Group Inc / IQVIA Holdings Inc / Korn Ferry / Mastercard Inc / Manhattan Associates Inc / Mattel Inc / Medpace Holdings Inc / Monolithic Power Systems Inc / Marathon Oil Corp / Matador Resources Co / NXP Semiconductors NV / NexPoint Residential Trust Inc / Organon & Co / Ovintiv Inc / PDC Energy Inc / Polaris Inc / Redfin Corp / Renewable Energy Group Inc / REX American Resources Corp / Relmada Therapeutics Inc / Renasant Corp / Spotify Technology SA / Shutterstock Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Stryker Corp / Teladoc Health Inc / TE Connectivity Ltd / Tenable Holdings Inc / TransUnion / Taysha Gene Therapies Inc / Visa Inc / Willis Towers Watson PLC / Western Union Co / Xilinx Inc / Zillow Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Ireland / Luxembourg / Netherlands / Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Intriguing pipeline deal adds a new pillar in Women’s Health</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">OGN</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Organon : Latest Thoughts On The Story; Updating Estimates Ahead of The Qtr</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Ms. Ekaterina V. Knyazkova / Christopher Neyor</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">R&D Pentathlon: Which Pharma's R&D Is Faster, Higher, Stronger?- Ahead of Curve</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / GB0009895292 / CH0012005267 / CH0012032048 / DK0060534915 / FR0000120578 / GB0009252882 / GB00BMVP7Y09 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Novartis AG / Roche Holding AG / Novo Nordisk A/S / Sanofi SA / GlaxoSmithKline PLC / Royalty Pharma PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">CA64079L1058 / DE0006231004 / DE0007164600 / GB00BMVP7Y09 / GB00BZ09BD16 / IE000GID8VI0 / IE00B4BNMY34 / IE00BK9ZQ967 / IE00BY7QL619 / IL0010824113 / IL0011334468 / IL0011571556 / IL0011762130 / KY30744W1070 / KYG037AX1015 / LU0974299876 / NL0000226223 / NL0009538784 / US00287Y1091 / US00724F1012 / US0079031078 / US0090661010 / US02080L1026 / US02156B1035 / US0231351067 / US02553E1064 / US03027X1000 / US03073E1055 / US03782L1017 / US0382221051 / US0396971071 / US0404131064 / US0463531089 / US07373B1098 / US09354A1007 / US09857L1089 / US0994061002 / US1005571070 / US1101221083 / US11135F1012 / US1265011056 / US1266501006 / US14149Y1082 / US14448C1045 / US1572101053 / US15961R1059 / US1727551004 / US17275R1023 / US18915M1071 / US1924461023 / US20717M1036 / US21036P1084 / US22160K1051 / US22788C1053 / US22822V1017 / US23355L1061 / US2545431015 / US2575541055 / US28414H1032 / US28623U1016 / US2910111044 / US29260V1052 / US29414B1044 / US30212P3038 / US30226D1063 / US3156161024 / US34959E1091 / US3647601083 / US37733W1053 / US38870X1046 / US39813G1094 / US39874R1014 / US43300A2033 / US4435731009 / US4456581077 / US4485791028 / US45167R1041 / US4567881085 / US4581401001 / US48203R1041 / US4824801009 / US49926T1043 / US5002551043 / US5017971046 / US5128071082 / US5184151042 / US5261071071 / US5324571083 / US5370081045 / US55306N1046 / US55405Y1001 / US55406W1036 / US55616P1049 / US5719032022 / US5738741041 / US58155Q1031 / US58933Y1055 / US5949181045 / US5950171042 / US5951121038 / US6098391054 / US64829B1008 / US6556641008 / US66987V1098 / US6701002056 / US67066G1040 / US6792951054 / US6821891057 / US68389X1054 / US68622V1061 / US69553P1003 / US6974351057 / US7170811035 / US7274931085 / US7392761034 / US74624M1027 / US74736K1016 / US7475251036 / US74767V1098 / US76674Q1076 / US7711951043 / US7761531083 / US7782961038 / US78410G1040 / US79466L3024 / US80105N1054 / US8030542042 / US8168501018 / US81762P1021 / US8269191024 / US82706C1080 / US83088M1027 / US8334451098 / US8486371045 / US8610121027 / US86646P1030 / US8725401090 / US8760301072 / US87612E1064 / US88076W1036 / US89677Q1076 / US89686D1054 / US8969452015 / US90138F1021 / US90364P1057 / US90384S3031 / US9222801022 / US9282981086 / US9311421039 / US9581021055 / US98138H1014 / US9839191015 / US98936J1016 / US98978V1035 / US98980G1022 / VGG273581030</td><td class="leftalignment">Neptune Wellness Solutions Inc / Infineon Technologies AG / SAP SE / Royalty Pharma PLC / Atlassian Corporation PLC / GH Research PLC / Accenture PLC / Trane Technologies PLC / Johnson Controls International PLC / Check Point Software Technologies Ltd / Cyberark Software Ltd / Tufin Software Technologies Ltd / Monday.Com Ltd / Farfetch Ltd / Ambarella Inc / Globant SA / STMicroelectronics NV / NXP Semiconductors NV / Abbvie Inc / Adobe Inc / Advanced Micro Devices Inc / Airbnb Inc / Alpha Teknova Inc / Alteryx Inc / Amazon.com Inc / American Eagle Outfitters Inc / American Tower Corp / Amerisourcebergen Corp / Appian Corp / Applied Materials Inc / Ardelyx Inc / Arista Networks Inc / AstraZeneca PLC / Beam Global / Blink Charging Co / Booking Holdings Inc / Boot Barn Holdings Inc / Boston Beer Company Inc / Bristol-Myers Squibb Co / Broadcom Inc / CTS Corp / CVS Health Corp / Cardinal Health Inc / Carrier Global Corp / CEVA Inc / ChargePoint Holdings Inc / Cirrus Logic Inc / Cisco Systems Inc / Cloudflare Inc / Cognizant Technology Solutions Corp / Confluent Inc / Constellation Brands Inc / Costco Wholesale Corp / CrowdStrike Holdings Inc / Crown Castle International Corp / DXC Technology Co / Diodes Inc / Domo Inc / Elanco Animal Health Inc / Elevation Oncology Inc / Emerson Electric Co / Endava PLC / Epam Systems Inc / Expedia Group Inc / Extreme Networks Inc / F5 Inc / Fortinet Inc / Gap Inc / GlaxoSmithKline PLC / Graphite Bio Inc / Grid Dynamics Holdings Inc / Grocery Outlet Holding Corp / Hilton Worldwide Holdings Inc / HubSpot Inc / J B Hunt Transport Services Inc / Hyatt Hotels Corp / IDEX Corp / Infosys Ltd / Intel Corp / Juniper Networks Inc / KLA Corp / Knowbe4 Inc / Kohls Corp / Bath & Body Works Inc / Lam Research Corp / Lattice Semiconductor Corp / Lennox International Inc / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / MACOM Technology Solutions Holdings Inc / MYT Netherlands Parent BV / Macy's Inc / Marriott International Inc / Marvell Technology Inc / Mckesson Corp / Merck & Co Inc / Microsoft Corp / Microchip Technology Inc / Micron Technology Inc / Monolithic Power Systems Inc / New Relic Inc / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Okta Inc / ON Semiconductor Corp / Oracle Corp / Organon & Co / PagerDuty Inc / Palo Alto Networks Inc / Pfizer Inc / Plantronics Inc / Power Integrations Inc / Pure Storage Inc / Qorvo Inc / Qualcomm Inc / Quantumscape Corp / Rimini Street Inc / Roche Holding AG / Romeo Power Inc / Ross Stores Inc / SBA Communications Corp / Salesforce.Com Inc / Sanofi SA / SAP SE / Semtech Corp / ServiceNow Inc / Silicon Laboratories Inc / Silicon Motion Technology Corp / Skyworks Solutions Inc / Snowflake Inc. / Splunk Inc / STMicroelectronics NV / Sumo Logic Inc / TJX Companies Inc / Tapestry Inc / Target Corp / Teradata Corp / Trip.com Group Ltd / Trivago NV / Tripadvisor Inc / Twilio Inc / UiPath Inc / Ulta Beauty Inc / Varonis Systems Inc / Vishay Intertechnology Inc / Walmart Inc / Western Digital Corp / Workday Inc / Xilinx Inc / Zendesk Inc / Zoetis Inc / Zscaler Inc / Despegar.com Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / France / Germany / India / Ireland / Israel / Luxembourg / Netherlands / Switzerland / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / INDUSTRY REPORTS / Research Digest</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / GB00BMVP7Y09 / US1101221083 / US28414H1032 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054 / US98978V1035</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Royalty Pharma PLC / Bristol-Myers Squibb Co / Elanco Animal Health Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA / Zoetis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Differentiated Strategy, Solid Management, But Stock A Wait And See</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharmaceutical Industry Pulse</td><td class="leftalignment">English</td><td class="rightalignment">1205</td><td class="leftalignment">GB00BMVP7Y09 / US00287Y1091 / US0463531089 / US1101221083 / US28414H1032 / US37733W1053 / US5324571083 / US58933Y1055 / US66987V1098 / US6701002056 / US68622V1061 / US7170811035 / US7711951043 / US80105N1054 / US98978V1035</td><td class="leftalignment">Royalty Pharma PLC / Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Elanco Animal Health Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S / Organon & Co / Pfizer Inc / Roche Holding AG / Sanofi SA / Zoetis Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / France / Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Precious Metal Stocks with Strong Buys</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ALS.TO / ABX.TO / FVI.TO / LRA.V / MD.V / OGN.V / OR.TO / PAAS.TO / VGZ.A</td><td class="leftalignment">Altius Minerals Corp / Barrick Gold Corp / Fortuna Silver Mines Inc / Lara Exploration Ltd / Midland Exploration Inc / Orogen Royalties Inc / Osisko Gold Royalties Ltd / Pan American Silver Corp / Vista Gold Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / SECTOR</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Yield Coverage Report : Healthcare</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AVTR.N / BHC.N / CHNG.O / CNC.N / CTLT.N / CYH.N / DVA.N / EHC.N / ENDP.O / HCA.N / HOLX.O / IQV.N / MD.N / MNKKQ.PK / MPLN.N / OGN.N / SEM / SYNH.O / TEVA.N / TFX / THC.N / UHS.N</td><td class="leftalignment">Avantor Inc / Bausch Health Companies Inc / Change Healthcare Inc / Centene Corp / Catalent Inc / Community Health Systems Inc / DaVita Inc / Encompass Health Corp / Endo International PLC / HCA Healthcare Inc / Hologic Inc / IQVIA Holdings Inc / MEDNAX Inc / Mallinckrodt PLC / Multiplan Corp / Organon & Co / Select Medical Holdings Corp / Syneos Health Inc / Teva Pharmaceutical Industries Ltd / Teleflex Inc / Tenet Healthcare Corp / Universal Health Services Inc</td><td class="leftalignment">FIXED INCOME - HIGH YIELD</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS</td><td class="leftalignment">David Common / Mr. Bradley H. Cobb</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZRX-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZRX.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">First Wave BioPharma Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RZLT-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">RZLT.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Rezolute Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PCSA-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PCSA.O / OGN / OILS.CD / ONPH.PK / ONTX.O</td><td class="leftalignment">Processa Pharmaceuticals Inc / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Cabot Wealth</td><td class="leftalignment">Initiating coverage of Organon & Co (OGN) with a Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">OGN=US</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">INITIATING COVERAGE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Bruce Kaser</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">00770K202 / 82982L103 / ABBV=US / AIN / AMED=US / AMGN=US / ARCB=US / ARQT=US / AVAH=US / AWI=US / AZEK=US / BECN=US / BIIB=US / BLD=US / BLDR=US / BMY=US / CBRL=US / CMG=US / CRSP=US / DENN=US / DIN=US / DRI=US / EDIT=US / EHC=US / ETSY=US / EXEL=US / EXP=US / FBHS=US / FERG=US / GFF=US / GMS=US / GPRE=US / HD=US / HUM=US / HXL=US / IBP=US / INCY=US / JACK=US / JELD=US / LEG=US / LHCG=US / LLY=US / LOCO=US / LOW=US / LSTR=US / MAS=US / MCD=US / MHK=US / MLM=US / NDLS=US / NTLA=US / OC=US / OGN / PFE=US / PGTI=US / PLAY=US / PNTG=US / PRPL=US / QSR=US / REGI=US / REX=US / RLMD=US / SAIA=US / SHAK=US / SPR=US / SWIM=US / TAST=US / TILE=US / TPX=US / TREX=US / VMC=US / VRTX=US / WEN=US / WING=US / WWD=US</td><td class="leftalignment">Aemetis Inc / SiteOne Landscape Supply Inc / Abbvie Inc / Albany International Corp / Amedisys Inc / Amgen Inc / ArcBest Corp / Arcutis Biotherapeutics Inc / Aveanna Healthcare Holdings Inc / Armstrong World Industries Inc / Azek Company Inc / Beacon Roofing Supply Inc / Biogen Inc / TopBuild Corp / Builders FirstSource Inc / Bristol-Myers Squibb Co / Cracker Barrel Old Country Store Inc / Chipotle Mexican Grill Inc / CRISPR Therapeutics AG / Denny's Corp / Dine Brands Global Inc / Darden Restaurants Inc / Editas Medicine Inc / Encompass Health Corp / ETSY Inc / Exelixis Inc / Eagle Materials Inc / Fortune Brands Home & Security Inc / Ferguson PLC / Griffon Corp / GMS Inc / Green Plains Inc / Home Depot Inc / Humana Inc / Hexcel Corp / Installed Building Products Inc / Incyte Corp / Jack in the Box Inc / JELD-WEN Holding Inc / Leggett & Platt Inc / LHC Group Inc / Eli Lilly and Co / El Pollo Loco Holdings Inc / Lowe's Companies Inc / Landstar System Inc / Masco Corp / McDonald's Corp / Mohawk Industries Inc / Martin Marietta Materials Inc / Noodles & Co / Intellia Therapeutics Inc / Owens Corning / Organon & Co / Pfizer Inc / PGT Innovations Inc / Dave & Buster's Entertainment Inc / Pennant Group Inc / Purple Innovation Inc / Restaurant Brands International Inc / Renewable Energy Group Inc / REX American Resources Corp / Relmada Therapeutics Inc / Saia Inc / Shake Shack Inc / Spirit AeroSystems Holdings Inc / Latham Group Inc / Carrols Restaurant Group Inc / Interface Inc / Tempur Sealy International Inc / Trex Company Inc / Vulcan Materials Co / Vertex Pharmaceuticals Inc / Wendys Co / Wingstop Inc / Woodward Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Jersey / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">What could be on OGN’s hunting list in Women’s Health?</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">OGN</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Nexplanon litigation updates</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for OGN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">68622V106</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">INM-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">INM.O / OFSA3.SA / OGN / OILS.CD / ONPH.PK</td><td class="leftalignment">InMed Pharmaceuticals Inc / Ouro Fino Saude Animal Participacoes SA / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SIOX-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SIOX.O / OFSA3.SA / OGN / OILS.CD / ONPH.PK</td><td class="leftalignment">Sio Gene Therapies Inc / Ouro Fino Saude Animal Participacoes SA / Organon & Co / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Organon : Initiating coverage at Underweight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">OGN.N / BHC.N / HOLX.O</td><td class="leftalignment">Organon & Co / Bausch Health Companies Inc / Hologic Inc</td><td class="leftalignment">FIXED INCOME - HIGH YIELD</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">David Common / Mr. Bradley H. Cobb</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Organon : Portfolio Evolution Will Take Time; Initiating Coverage With A Neutral Rating, $38 PT</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">OGN.N / MRK.N</td><td class="leftalignment">Organon & Co / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Organon : Portfolio Evolution Will Take Time; Initiating Coverage With A Neutral Rating, $38 PT</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">OGN.N</td><td class="leftalignment">Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Christopher T. Schott, CFA / Xiling Chen / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">00770K202 / 67421J108 / 82982L103 / ABBV=US / ADS=US / APEI=US / AUTL=US / AWI=US / AXNX=US / AZEK=US / BDSI=US / BECN=US / BIIB=US / BLD=US / BLDR=US / COLL=US / CRSP=US / EXP=US / FBHS=US / FERG=US / FOCS=US / GBT=US / GFF=US / GMS=US / GPRE=US / HD=US / IBP=US / INCY=US / JELD=US / LEG=US / LOW=US / MAS=US / MEIP=US / MHK=US / MLM=US / MRK=US / OC=US / OGN / PFE=US / PGTI=US / PRPL=US / PTCT=US / REGI=US / SWIM=US / TILE=US / TPX=US / TREX=US / VMC=US / VRTX=US / WAL=US / ZI=US / ZTS=US</td><td class="leftalignment">Aemetis Inc / Oatly Group AB / SiteOne Landscape Supply Inc / Abbvie Inc / Alliance Data Systems Corp / American Public Education Inc / Autolus Therapeutics PLC / Armstrong World Industries Inc / Axonics Inc / Azek Company Inc / BioDelivery Sciences International Inc / Beacon Roofing Supply Inc / Biogen Inc / TopBuild Corp / Builders FirstSource Inc / Collegium Pharmaceutical Inc / CRISPR Therapeutics AG / Eagle Materials Inc / Fortune Brands Home & Security Inc / Ferguson PLC / Focus Financial Partners Inc / Global Blood Therapeutics Inc / Griffon Corp / GMS Inc / Green Plains Inc / Home Depot Inc / Installed Building Products Inc / Incyte Corp / JELD-WEN Holding Inc / Leggett & Platt Inc / Lowe's Companies Inc / Masco Corp / MEI Pharma Inc / Mohawk Industries Inc / Martin Marietta Materials Inc / Merck & Co Inc / Owens Corning / Organon & Co / Pfizer Inc / PGT Innovations Inc / Purple Innovation Inc / PTC Therapeutics Inc / Renewable Energy Group Inc / Latham Group Inc / Interface Inc / Tempur Sealy International Inc / Trex Company Inc / Vulcan Materials Co / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / ZoomInfo Technologies Inc / Zoetis Inc</td><td class="leftalignment"></td><td class="leftalignment">Jersey / Sweden / Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Our spin on spins</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">OGN / ABBV=US / MRK=US / PFE=US / ZTS=US</td><td class="leftalignment">Organon & Co / Abbvie Inc / Merck & Co Inc / Pfizer Inc / Zoetis Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">initiating coverage</td><td class="leftalignment">English</td><td class="rightalignment">113</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">What Is Driving Gold? Inflation and Basel</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DEX.V / ABX.TO / AMZ.V / FVI.TO / LRA.V / MD.V / NEM.N / OGN.V / OR.TO</td><td class="leftalignment">Almadex Minerals Ltd / Barrick Gold Corp / Azucar Minerals Ltd / Fortuna Silver Mines Inc / Lara Exploration Ltd / Midland Exploration Inc / Newmont Corporation / Orogen Royalties Inc / Osisko Gold Royalties Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / INVESTMENT STRATEGY / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / PORTFOLIO STRATEGY / SECTOR</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">82982L103 / ABBV=US / AMGN=US / APTS=US / AUTL=US / AZEK=US / BCO=US / BDN=US / BECN=US / BLD=US / BLDR=US / BMY=US / BNL=US / CHRS=US / COLD=US / CRSP=US / DASH=US / DEA=US / DIN=US / DRE=US / DRI=US / EGP=US / ENDP=US / EOLS=US / EXP=US / GBT=US / GILD=US / GL=US / GMAB=US / HIW=US / HTRG=US / IBP=US / INCY=US / KIM=US / KTOS=US / LEG=US / LSI=US / MAA=US / MEIP=US / MHK=US / MLM=US / MRK=US / NTST=US / OC=US / OGN / OLO=US / PAA=US / PATH=US / PFE=US / PGTI=US / PRI=US / REGN=US / THO=US / TILE=US / TPX=US / TREX=US / TXRH=US / UBER=US / UDR=US / VMC=US / VRTX=US / VTRS=US / YEXT=US</td><td class="leftalignment">SiteOne Landscape Supply Inc / Abbvie Inc / Amgen Inc / Preferred Apartment Communities Inc / Autolus Therapeutics PLC / Azek Company Inc / Brinks Co / Brandywine Realty Trust / Beacon Roofing Supply Inc / TopBuild Corp / Builders FirstSource Inc / Bristol-Myers Squibb Co / Bunzl plc / Coherus BioSciences Inc / Americold Realty Trust / CRISPR Therapeutics AG / DoorDash Inc / Easterly Government Properties Inc / Dine Brands Global Inc / Duke Realty Corp / Darden Restaurants Inc / Eastgroup Properties Inc / Endo International PLC / Evolus Inc / Eagle Materials Inc / Global Blood Therapeutics Inc / Gilead Sciences Inc / Globe Life Inc / Genmab A/S / Highwoods Properties Inc / Heritage Insurance Holdings Inc / Installed Building Products Inc / Incyte Corp / Kimco Realty Corp / Kratos Defense and Security Solutions Inc / Leggett & Platt Inc / Life Storage Inc / Mid-America Apartment Communities Inc / MEI Pharma Inc / Mohawk Industries Inc / Martin Marietta Materials Inc / Merck & Co Inc / Netstreit Corp / Owens Corning / Organon & Co / Olo Inc / Plains All American Pipeline LP / UiPath Inc / Pfizer Inc / PGT Innovations Inc / Primerica Inc / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Interface Inc / Tempur Sealy International Inc / Trex Company Inc / Texas Roadhouse Inc / Uber Technologies Inc / UDR Inc / Vulcan Materials Co / Vertex Pharmaceuticals Inc / Viatris Inc / Yext Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">Equity / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Time to take a look – reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">OGN / MRK=US / VTRS=US</td><td class="leftalignment">Organon & Co / Merck & Co Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Initiation: Differentiated Strategy, Solid Management, But Stock A Wait And See</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US68622V1061</td><td class="leftalignment">Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Orogen Royalties Inc</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">OGN.V</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Money Manager Provides Updates on Companies to Buy, Hold and Watch</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">WPM.TO / ALS.TO / FNV.TO / FVI.TO / HPHT-D.SI / L.N / LRA.V / MD.V / OGN.V</td><td class="leftalignment">Wheaton Precious Metals Corp / Altius Minerals Corp / Franco-Nevada Corp / Fortuna Silver Mines Inc / Hutchison Port Holdings Trust / Loews Corp / Lara Exploration Ltd / Midland Exploration Inc / Orogen Royalties Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Singapore / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / INVESTMENT STRATEGY / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / PORTFOLIO STRATEGY / SECTOR</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Orogen Royalties Inc Build Solid Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">OGN.V</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Outlook Improving for Gold and Resource Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ALS.TO / ABX.TO / FNV.TO / FVI.TO / LRA.V / MD.V / OGN.V / RGLD.OQ / WPM.TO</td><td class="leftalignment">Altius Minerals Corp / Barrick Gold Corp / Franco-Nevada Corp / Fortuna Silver Mines Inc / Lara Exploration Ltd / Midland Exploration Inc / Orogen Royalties Inc / Royal Gold Inc / Wheaton Precious Metals Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / INVESTMENT STRATEGY / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / PORTFOLIO STRATEGY / SECTOR</td><td class="leftalignment">COMMODITY RESEARCH / INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Royalty Companies and Explorers Are On Sale</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ALS.TO / ABX.TO / FNV.TO / FVI.TO / LRA.V / MD.V / OGN.V / OR.TO / RGLD.OQ / WPM.TO</td><td class="leftalignment">Altius Minerals Corp / Barrick Gold Corp / Franco-Nevada Corp / Fortuna Silver Mines Inc / Lara Exploration Ltd / Midland Exploration Inc / Orogen Royalties Inc / Osisko Gold Royalties Ltd / Royal Gold Inc / Wheaton Precious Metals Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / INVESTMENT STRATEGY / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / PORTFOLIO STRATEGY / SECTOR</td><td class="leftalignment">Equity / INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Gold and Miners Oversold, with Strong Outlook</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABX.TO / FNV.TO / LRA.V / NEM.N / NESN.S / OGN.V / OR.TO / WPM.TO</td><td class="leftalignment">Barrick Gold Corp / Franco-Nevada Corp / Lara Exploration Ltd / Newmont Corporation / Nestle SA / Orogen Royalties Inc / Osisko Gold Royalties Ltd / Wheaton Precious Metals Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / INVESTMENT STRATEGY / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / PORTFOLIO STRATEGY / SECTOR</td><td class="leftalignment">COMMODITY RESEARCH / MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Gold Miners Recovered from COVID but Stocks Undervalued</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABX.TO / FNV.TO / FVI.TO / LRA.V / MD.V / NEM.N / NESN.S / OGN.V / OR.TO / RGLD.OQ / WPM.TO / YRI.TO</td><td class="leftalignment">Barrick Gold Corp / Franco-Nevada Corp / Fortuna Silver Mines Inc / Lara Exploration Ltd / Midland Exploration Inc / Newmont Corporation / Nestle SA / Orogen Royalties Inc / Osisko Gold Royalties Ltd / Royal Gold Inc / Wheaton Precious Metals Corp / Yamana Gold Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / United States</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">COMMENTARY / COMMODITIES / COMPANY / EQUITY / INDUSTRY / INDUSTRY OVERVIEW / INVESTMENT STRATEGY / MARKET ANALYSIS / MARKET COMMENT / OVERVIEW / PORTFOLIO STRATEGY / SECTOR</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Adrian Day</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Orogen Royalties Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">OGN.V</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Orogen Royalties Inc Build Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">OGN.V</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Orogen Royalties Inc</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">OGN.V</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Orogen Royalties Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">OGN.V</td><td class="leftalignment">Orogen Royalties Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Chemicals / Containers & Packing / Fertilizers / Manufacturing / Metals & Minerals / Paper & Forest Products</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
</tbody></table>
</body>
</html>